Heparan Sulfate Proteoglycans Stephane Sarrazin 1 , William C . Lamanna 1 , and Jeffrey D . Esko Department of Cellular and Molecular Medicine , Glycobiology Research and Training Center , University of California , San Diego , La Jolla , California 92093 Correspondence : jesko @ ucsd . edu Heparan sulfate proteoglycans are found at the cell surface and in the extracellular matrix , where they interact with a plethora of ligands . Over the last decade , new insights have emerged regarding the mechanism and biological signiﬁcance of these interactions . Here , we discuss changing views on the speciﬁcity of protein – heparan sulfate binding and the activityofHSPGsasreceptorsandcoreceptors . Althoughfewinnumber , heparansulfatepro - teoglycans have profound effects at the cellular , tissue , and organismal level . H eparan sulfate proteoglycans ( HSPGs ) are glycoproteins , with the common charac - teristic of containing one or more covalently attached heparan sulfate ( HS ) chains , a type of glycosaminoglycan ( GAG ) ( Esko et al . 2009 ) . Cells elaborate a relatively small set of HSPGs ( (cid:2) 17 ) that fall into three groups according to their location : membrane HSPGs , such as syn - decans and glycosylphosphatidylinositol - anch - ored proteoglycans ( glypicans ) , the secreted extracellular matrix HSPGs ( agrin , perlecan , type XVIII collagen ) , and the secretory vesicle proteoglycan , serglycin ( Table 1 ) . Much of the early work in the ﬁeld concentrated on compo - sition ( size , chain number , and structure of the HS chains ) , biosynthesis , and binding proper - ties of the chains . In 1985 , the ﬁrst somatic cell mutants altered in HSPG expression were identiﬁed ( Esko et al . 1985 ) , which allowed functional studies in the context of a cell culture model ( Zhang et al . 2006 ) . A decade later , the ﬁrst HSPG mutants in a model organism ( Drosophila melanogaster ) were identiﬁed ( Ro - galski et al . 1993 ; Nakato et al . 1995 ; Ha¨cker et al . 1997 ; Bellaiche et al . 1998 ; Lin et al . 1999 ) , which was followed by identiﬁcation of mutants in nematodes , tree frogs , zebraﬁsh , and mice ( Tables 2 and 3 ) . HS is evolutionarily ancient and its composition has remained rela - tively constant from Hydra to humans ( Yamada et al . 2007 ; Lawrence et al . 2008 ) . Figure 1 shows in pictorial form manyof the systems in which HSPGs participate . 1 . HSPGs are present in basement membranes ( perlecan , agrin , and collagen XVIII ) , where they collaborate with other matrix compo - nents to deﬁne basement membrane structure and to provide a matrix for cell migration . 2 . HSPGs are found in secretory vesicles , most notably serglycin , which plays a role in packaging granular contents , maintaining proteases in an active state , and regulating various biological activities after secretion 1 These authors contributed equally to this work . Editors : Richard Hynes and Kenneth Yamada Additional Perspectives on Extracellular Matrix Biology available at www . cshperspectives . org Copyright # 2011 Cold Spring Harbor Laboratory Press ; all rights reserved ; doi : 10 . 1101 / cshperspect . a004952 Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 1 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from such as coagulation , host defense , and wound repair . 3 . HSPGs can bind cytokines , chemokines , growth factors , and morphogens , protecting them against proteolysis . These interactions provide a depot of regulatory factors that can be liberated by selective degradation of the HS chains . They also facilitate the forma - tion of morphogen gradients essential for cell speciﬁcation during development and chemokine gradients involved in leukocyte recruitment and homing . 4 . HSPGs can act as receptors for proteases and protease inhibitors regulating their spatial distribution and activity . 5 . Membrane proteoglycans cooperate with integrins and other cell adhesion receptors Table 1 . Heparan sulfate proteoglycans Class Proteoglycan Core mass ( kDa ) a Chain type ( number ) b Tissue Human disease Membrane - bound Syndecan - 1 – syndecan - 4 31 – 45 HS ( 2 – 3 ) in Sdc2 and Sdc4 ; HS / CS ( 3 – 4 HS / 1 - 2 CS ) in Sdc1 and Sdc3 Epithelial cells , ﬁbroblasts Glypican - 1 – glypican - 6 57 – 69 HS ( 1 – 3 ) Epithelial cells , ﬁbroblasts Simpson – Golabi – Behmel syndrome ( overgrowth ) ( GPC3 ) ( Pilia et al . 1996 ) ; omodysplasia ( skeletal dysplasia ) ( GPC6 ) ( Campos - Xavier et al . 2009 ) Betaglycan ( part - time PG ) 110 HS / CS ( 1 – 2 ) Fibroblasts Neuropilin - 1 ( part - time PG ) 130 HS or CS ( 1 ) Endothelial cells CD44v3 37 HS ( 1 ) Lymphocytes Secretoryvesicles Serglycin 10 – 19 Heparin / CS ( 10 – 15 ) Mast cells , hematopoieticcells Extracellularmatrix Perlecan 400 HS ( 1 – 4 ) Basementmembranes Schwartz – Jampel syndrome ( skeletal dysplasia ) ( Nicole 2000 ; Arikawa - Hirasawa et al . 2001 ) Agrin 212 HS ( 2 – 3 ) Basementmembranes Collagen XVIII 150 HS ( 1 – 3 ) Epithelial cells , basementmembranes Knobloch syndrome type I ( Sertie et al . 2000 ) HS , heparan sulfate ; CS , chondroitin sulfate ; PG , proteoglycan . a The variation in core mass is because of species differences . b The number of chains is based on the number of putative attachment sites for chain initiation as well as data from the literature ; the actual number of chains varies by method , tissue , and species . S . Sarrazin et al . 2 Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from to facilitate cell - ECM attachment , cell – cell interactions , and cell motility . 6 . Membrane HSPGs act as coreceptors for various tyrosine kinase - type growth factor receptors , lowering their activation thresh - old or changing the duration of signaling reactions . 7 . Membrane HSPGs act as endocytic receptors for clearance of bound ligands , which is es - pecially relevant in lipoprotein metabolism in the liver and perhaps in the formation of morphogen gradients during development . This article is divided into 10 subsections . The ﬁrst three are written for investigators outside the ﬁeld who may need some back - ground information on the diversity of HSPGs and the interactions that occur with protein ligands . The subsequent sections describe seven systems that illustrate general principles or ideas that have undergone a signiﬁcant shift over the last decade . Because of space limi - tations not all subjects can be considered or treated in appropriate depth and therefore the reader is referred to excellent recent review articles ( Tkachenko et al . 2005 ; Bulow and Hobert 2006 ; Bishop et al . 2007 ; Lamanna et al . 2007 ; Bix and Iozzo 2008 ; Filmus et al . 2008 ; Ori et al . 2008 ; Rodgers et al . 2008 ; Sanderson and Yang 2008 ; Iozzo et al . 2009 ; Couchman 2010 ) . Table 2 . Mutants altered in HSPG core proteins Gene Proteoglycan Phenotype ( references ) Sdc1 Syndecan - 1 Null allele : viable ; increase in inﬂammation - mediated corneal angiogenesis ( Gotte et al . 2002 , 2005 ) ; corneal epithelial cells migrate more slowly , show reduced localization of a 9 integrin during wound closure and fail to increase in proliferation after wounding ( Stepp et al . 2002 ) ; enhanced leukocyte - endothelial interaction in the retina ( Gotte et al . 2002 , 2005 ) ; increase in medial and intimal smooth muscle cell replication and neointimal lesion after injury ( Fukai et al . 2009 ) ; reduced cardiac ﬁbrosis and dysfunction during angiotensin II – induced hypertension ( Schellings et al . 2010 ) ; not required for follicle initiation and development ( Richardson et al . 2009 ) ; accumulates plasma triglycerides , and shows prolonged circulation of injected human VLDL and intestinally derived chylomicrons ( Stanford et al . 2009 ) ; juvenile mice resistant to carcinogen - induced tumorigenesis ( McDermott et al . 2007 ) ; increased basal protein leakage and more susceptible to protein loss induced by combinations of IFN - g , TNF - a , and increased venous pressure ( Bode et al . 2008 ) ; exacerbates anti - GBM nephritis shifting Th1 / Th2 balance toward a Th2 response ( Rops et al . 2007 ) ; no role in hepatocyte infection by Plasmodium yoelii sporozoites ( Bhanot 2002 ) ; normal larval development of Trichinella spiralis , but modestly reduced Th2 responses during infection ( Beiting et al . 2006 ) ; less susceptible to Pseudomonas aeruginosa infection ( Haynes et al . 2005 ) ; reduced P . aeruginosa infection rate and virulence ( Park et al . 2001 ) ; protected from Staphylococcus aureus beta - toxin - induced lung injury ( Hayashida et al . 2009a ) ; exaggerated airway hyperresponsiveness , eosinophilia , and lung IL - 4 responses to allergens ( Xu et al . 2005 ) ; exaggerated CXC chemokines , neutrophilic inﬂammation , organ damage , and lethality in LPS endotoxemia ( Hayashida et al . 2009b ) ; prolonged recruitment of inﬂammatory cells in dextran sodium sulfate ( DSS ) - induced colitis and delayed type hypersensitivity ( Masouleh et al . 2009 ; Floer et al . 2010 ) . Continued Heparan Sulfate Proteoglycans Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 3 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from Table 2 . Continued Gene Proteoglycan Phenotype ( references ) Sdc2 Syndecan - 2 No mutants reported . Sdc2 antisense impairs angiogenesis in human microvascular endothelial cells ( Noguer et al . 2009 ) ; morpholinos inhibit cell migration and ﬁbrillogenesis during embryogenesis in zebraﬁsh ( Arrington and Yost 2009 ) . Sdc3 Syndecan - 3 Null allele : viable ; altered feeding behavior ( Straderet al . 2004 ) ; no phenotype in synovial endothelial cells ( Patterson et al . 2005 ) ; enhanced long - term potentiation ( LTP ) in area CA1 ( brain ) and impaired performance in tasks assessing hippocampal function ( Kaksonen et al . 2002 ) ; more sensitive to inhibition of food intake by the melanocortin agonist MTII ( Reizes et al . 2003 ) ; perturbs laminar structure of the cerebral cortex as a result of impaired radial migration , and neural migration in the rostral migratory stream is impaired ( Hienola et al . 2006 ) ; novel form of muscular dystrophy characterized by impaired locomotion , ﬁbrosis , and hyperplasia of myonuclei and satellite cells ( Cornelison et al . 2004 ) . Sdc4 Syndecan - 4 Null allele : viable ; enhanced ﬁbrin deposition in degenerating fetal vessels in the placental labyrinth ( Ishiguro et al . 2000 ) ; delayed angiogenesis in wound granulation tissue ( Echtermeyer et al . 2001 ) ; defective subcellular localization of mTOR Complex2 and Akt activation in endothelial cells , affecting endothelial cell size , NOS , and arterial blood pressure ( Partovian et al . 2008 ) ; decreased macrophage uptake of phospholipase A2 - modiﬁed LDL ( Boyanovsky et al . 2009 ) ; mesangial expansion , enhanced matrix collagens I and IV , ﬁbronectin and focal segmental glomerulosclerosis in males , and induction of Sdc2 in glomeruli ( Cevikbas et al . 2008 ) ; more susceptible to hepatic injury , and thrombin - cleaved form of osteopontin is signiﬁcantly elevated after concanavalin - A injection ( Kon et al . 2008 ) ; less damage in osteoarthritic cartilage in a surgically induced model of osteoarthritis ( Echtermeyer et al . 2009 ) ; explanted satellite cells fail to reconstitute damaged muscle and are deﬁcient in activation , proliferation , MyoD expression , myotube fusion , and differentiation ( Cornelison et al . 2004 ) ; vibrissae are shorter and have a smaller diameter because of suboptimal response to ﬁbroblast growth factors ( Iwabuchi and Goetinck 2006 ) ; lower phosphorylation levels of focal adhesion kinase ( Wilcox - Adelman et al . 2002 ) ; random migration of ﬁbroblasts as a result of high delocalized Rac1 activity ( Bass et al . 2007 ) ; defective RGD - independent cell attachment to transglutaminase - ﬁbronectin matrices ( Telci et al . 2008 ) ; impaired suppression of production of IL - 1 b by TGF - a ( Ishiguro et al . 2002 ) ; decreased neutrophil recruitment and increased myoﬁbroblast recruitment and interstitial ﬁbrosis after bleomycin - treatment , no inhibition of ﬁbrosis with recombinant CXCL10 protein ( Jiang et al . 2010 ) ; hypersensitivity to LPS because of decreased TGF - b suppression of IL - 1 production in monocytes and neutrophils ( Ishiguro et al . 2001 ) . Gpc1 Glypican - 1 Null allele : viable ; reduced brain size ( Jen et al . 2009 ) . Athymic mutant mice show decreased tumor angiogenesis and metastasis ( Aikawa et al . 2008 ) . Gpc2 Glypican - 2 No mutants reported . Continued S . Sarrazin et al . 4 Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from Table 2 . Continued Gene Proteoglycan Phenotype ( references ) Gpc3 Glypican - 3 Null allele : viable ; resembles Simpson – Golabi – Behmel overgrowth syndrome , including somatic overgrowth , renal dysplasia , accessory spleens , polydactyly , and placentomegaly ( Cano - Gauci et al . 1999 ; Chiao et al . 2002 ) ; defects in cardiac and coronary vascular development ( Ng et al . 2009 ) ; alterations in Wnt signaling , in vivo inhibition of the noncanonical Wnt / JNK signaling , activation of canonical Wnt / b - catenin signaling ( Song et al . 2005 ) ; increased Hedgehog signaling ( Capurro et al . 2008 ) ; abnormal rates of proliferation and apoptosis in cortical and medullary collecting duct cells ( Grisaru et al . 2001 ) ; delay in endochondral ossiﬁcation , impairment in the development of the myelomonocytic lineage ( Viviano et al . 2005 ) . Gpc4 Glypican - 4 Zebraﬁsh knypek controls cell polarity during convergent extension ( Topczewski et al . 2001 ) ; craniofacial skeletal defects in adult ﬁsh ( LeClair et al . 2009 ) . Gpc5 Glypican - 5 No mutants reported . Gpc6 Glypican - 6 Impaired endochondral ossiﬁcation and omodysplasia ( Campos - Xavier et al . 2009 ) . Tgfbr3 Betaglycan Null allele : embryonic lethal ; heart and liver defects ( Stenvers et al . 2003 ) ; defect in seminiferous cord formation in E12 . 5 – 13 . 5 embryos ( Sarraj et al . 2010 ) . Hspg2 Perlecan Null allele : embryonic lethal ( E10 – 12 ) ; developmental angiogenesis altered in zebraﬁsh ( Zoeller et al . 2009 ) ; high incidence of malformations of the cardiac outﬂow tract , lack of well - deﬁned spiral endocardial ridges ( Costell et al . 2002 ) ; lower amounts of collagen IVand laminins in embryonic hearts , reduced function in infarcted hearts from heterozygous mice ( Sasse et al . 2008 ) ; absence of acetylcholinesterase at the neuromuscular junctions ( Arikawa - Hirasawa et al . 2002 ) ; cephalic and skeletal abnormalities ( Arikawa - Hirasawa et al . 1999 ) ; cerebral ectopias , exencephaly ( Giro´s et al . 2007 ) ; increased cross - sectional area of myosin heavy chain type IIb ﬁbers in the tibialis anterior muscle ( Xu et al . 2010b ) ; diminished osteocyte canalicular pericellular area ( Thompson et al . 2011 ) . Exon3deletion ( Hspg2 3 / 3 ) viable : proteinuriaafterproteinloading ( Moritaetal . 2005 ) ; monocyte / macrophage inﬂux impaired in Hspg2 3 / 3 Col18a1 2 / – mice in a model of renal ischemia / reperfusion ( Celie et al . 2007 ) . Secreted as CSPG in some tissues ( Danielson et al . 1992 ; Govindraj et al . 2002 ; Vogl - Willis and Edwards 2004 ; West et al . 2006 ) , but relationship of CSPG isoform to phenotypes not established . Prg1 Serglycin Null allele : viable ; secretory granule defects in mast cells ( Abrink et al . 2004 ) ; dense core formation is defective in mast cell granules ( Henningsson et al . 2006 ) ; defective secretory granule maturation and granzyme B storage in cytotoxic T cells ( Grujic et al . 2005 ) ; no effect on macrophages ( Zernichow et al . 2006 ) ; platelets and megakaryocytes contain unusual scroll - like membranous inclusions ( Woulfe et al . 2008 ) ; enlargement of multiple lymphoid organs , decrease in the proportion of CD4 þ cells , more pronounced airway inﬂammatory response in older mice ( Wernersson et al . 2009 ) ; increased virulence of Klebsiella pneumoniae ( Niemann et al . 2007 ) ; defective regulation of antiviral CD8 þ T - cell responses ( Grujic et al . 2008 ) . Continued Heparan Sulfate Proteoglycans Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 5 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from Table 2 . Continued Gene Proteoglycan Phenotype ( references ) Agrn Agrin Null allele : embryonic lethal ; reduced number , size , and density of postsynaptic acetylcholine receptor aggregates in muscles ; abnormal intramuscular nerve branching and presynaptic differentiation ( Gautam et al . 1996 , 1999 ) ; smaller brains ( Serpinskaya et al . 1999 ) ; abnormal development of interneuronal synapses ( Gingras et al . 2007 ) ; increased resistance to excitotoxic injury ( Hilgenberg et al . 2002 ) ; reduced number of cortical presynaptic and postsynaptic specializations ( Ksiazek et al . 2007 ) . Floxed allele : Inactivation in podocytes does not affect glomerular charge selectivity or glomerular architecture ( Harvey et al . 2007 ) . Col18a1 Collagen XVIII Null allele : viable ; increased microvascular growth ( Li and Olsen 2004 ) ; increased angiogenesis associated with atherosclerotic plaques ( Moulton et al . 2004 ) ; delayed regression of blood vessels in the vitreous along the surface of the retina after birth and lack of or abnormal outgrowth of retinal vessels ( Fukai et al . 2002 ) ; larger choroidal neovascularization lesions and increased vascular leakage ( Marneros et al . 2007 ) ; accelerated healing and vascularization rate of excisional dorsal skin wounds ( Seppinen et al . 2008 ) ; anomalous anastomoses of vasculature ; disruption of the posterior iris pigmentepithelial cell layer withrelease ofmelanin granules , severethickening of the stromal iris basement membrane zone ( Marneros and Olsen 2003 ) ; increase in the amount of retinal astrocytes ( Hurskainen et al . 2005 ) ; more severe glomerular and tubulointerstitial injury in induced anti - GBM glomerulonephritis ( Hamano et al . 2010 ) ; monocyte / macrophage inﬂux impaired in Hspg2 3 / 3 Col18a1 2 / – mice in a model of renal ischemia / reperfusion ( Celie et al . 2007 ) ; mild chylomicronemia ( Bishop et al . 2010 ) . Table 3 . Mouse mutants altered in HS biosynthesis Gene Enzyme Phenotype Xt1 Xylosyltransferase - 1 No mutants reported . Xt2 Xylosyltransferase - 2 Null allele : viable ; polycystic kidney and livers ( Condac et al . 2007 ) . GalTI ( b 4GalT7 ) Galactosyltransferase I Human mutants : defective chondroitin substitution of decorin and biglycan in an Ehlers – Danlos patient ( Gotte and Kresse 2005 ; Seidler et al . 2006 ) . GalTII ( b 3GalT6 ) Galactosyltransferase II No mutants reported . Glcat1 Glucuronyltransferase I Null allele : embryonic lethal ( 4 – 8 - cell stage ) ( Izumikawa et al . 2010 ) . Extl3 N - acetylglucosaminyltransferaseI Floxed allele : Inactivation in islets decreases growth and insulin secretion ( Takahashi et al . 2009 ) . Ext1 / Ext2 HS Copolymerase ( N - acetylglucosaminyl - glucuronyltransferase ) Null allele : embryonic lethal ( E6 - 7 . 5 ) ; lack of mesoderm differentiation ( Lin et al . 2000 ; Stickens et al . 2005 ) ; heterozygotes develop rib growth plate exostoses ( Stickens et al . 2005 ; Zak et al . 2011 ) ; unaltered vascular permeability in heterozygous mice ( Xu et al . 2010a ) . Continued S . Sarrazin et al . 6 Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from Table 3 . Continued Gene Enzyme Phenotype Floxed allele of Ext1 : defective brain morphogenesis and midline axon guidance after nestin - Cre inactivation ( Inatani et al . 2003 ) ; no effect on adaptive immune response in CD15Cre mice ( Garner et al . 2008 ) ; altered T - cell and dendritic cell homing to lymph nodes in Tie2Cre mice ( Bao et al . 2010 ) ; rib growth plate exostosis formation in Col2Cre mice ( Jones et al . 2010 ; Matsumoto et al . 2010 ; Zak et al . 2011 ) . Ndst1 N - acetylglucosaminylN - deacetylase / N - sulfotransferase - 1 Null allele : Perinatal lethal ; lung hypoplasia , defective forebrain , lens , and skull development ( Fan et al . 2000 ; Ringvall et al . 2000 ; Grobe et al . 2005 ; Pan et al . 2006 ) . Floxed allele : decreased chemokine transcytosis and presentation and neutrophil inﬁltration in Tie2Cre mice ( Wang et al . 2005 ) ; decreased allergen - induced airway hyperresponsiveness and inﬂammation because of reduction in recruitment of eosinophils , macrophages , neutrophils , and lymphocytes in Tie2Cre mice ( Zuberi et al . 2009 ) ; decreased pathological angiogenesis in Tie2Cre mice ( Fuster et al . 2007 ) ; decreased vascular VEGF - induced hyperpermeability ( Xu et al . 2010a ) ; decreased vascular smooth muscle cell proliferation , vessel size , and vascular remodeling after arterial injury in SM22 a Cre mice ( Adhikari et al . 2010a ) ; mild effect on T - cell response in Tie2Cre ; Ndst2 2 / 2 mice ( Garner et al . 2008 ) ; defective lacrimal gland development and Fgf10 - Fgfr2b complex formation and signaling in LeCre mice ( Pan et al . 2008 ) ; defective lobuloalveolar developmentinmammarygland ( Crawfordetal . 2010 ) . Ndst2 N - acetylglucosaminylN - deacetylase / N - sulfotransferase - 2 Null allele : viable ; mast cell deﬁciency and defective storage of proteases ( Forsberg et al . 1999 ; Humphries et al . 1999 ) ; compounding mutation with Ndst1 reduces L - selectin interactions ( Wang et al . 2005 ) . Ndst3 N - acetylglucosaminyl N - deacetylase / N - sulfotransferase - 3 Null allele : viable ; ﬂoxed allele available ( Pallerla et al . 2008 ) . Ndst4 N - acetylglucosaminylN - deacetylase / N - sulfotransferase - 4 No mutants reported . Glce Uronyl C5 epimerase Null allele : perinatal lethal ; renal agenesis ( Li et al . 2003 ) . H2st Uronyl 2 - O - sulfotransferase Null allele : perinatal lethal ; renal agenesis ; skeletal and ocular defects ( Bullock et al . 1998 ; Merry et al . 2001 ) ; defective cerebral cortical development ( McLaughlin et al . 2003 ) ; altered lacrimal gland development ( Qu et al . 2011 ) . Floxed allele : altered lipoprotein clearance in AlbCre mice ( Stanford et al . 2010 ) ; altered branching morphogenesis in the mammary gland ( Garner et al . 2011 ) . Continued Heparan Sulfate Proteoglycans Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 7 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from Table 3 . Continued Gene Enzyme Phenotype H3st1 Glucosaminyl 3 - O - sulfotransferase 1 Null allele : partially penetrant lethality ; no alteration in coagulation ( HajMohammadi et al . 2003 ) ; fertility defects because of impaired ovarian function and placenta development ( Shworak et al . 2002 ; HajMohammadi et al . 2003 ) . H3st2 Glucosaminyl 3 - O - sulfotransferase 2 Null allele ; viable ; no neuronal phenotype ( Hasegawa and Wang 2008 ) . H3st3 Glucosaminyl 3 - O - sulfotransferase 3 No mutants reported . H3st4 Glucosaminyl 3 - O - sulfotransferase 4 No mutants reported . H3st5 Glucosaminyl 3 - O - sulfotransferase 5 No mutants reported . H3st6 Glucosaminyl 3 - O - sulfotransferase 6 No mutants reported . H6st1 Glucosaminyl 6 - O - sulfotransferase 1 Nullallele : embryonic lethal ( Habuchi etal . 2007 ; Sugaya et al . 2008 ) . Gene trap allele : embryonic lethal ; retinal axon guidance defects ( Pratt et al . 2006 ) . Floxed allele : systemic inactivation embryonic lethal ( Izvolsky et al . 2008 ) ; no change in plasma triglycerides in AlbCre mice ( Stanford et al . 2010 ) . H6st2 Glucosaminyl 6 - O - sulfotransferase 2 Null allele : viable ( Sugaya et al . 2008 ) ; HS6ST - 2 , but not HS6ST - 1 , morphants in zebraﬁsh show abnormalities in the branching morphogenesis of the caudal vein ( Chen et al . 2005 ) . H6st3 Glucosaminyl 6 - O - sulfotransferase 3 No mutants reported . Hpa Heparanase , transgene Accelerated wound angiogenesis , enhanced delayed type hypersensitivity response ( Zcharia et al . 2005 ; Edovitskyetal . 2006 ; Ilan etal . 2006 ) ; accumulation of intracellular crystals of protein Ym1 in macrophages ( Waern et al . 2010 ) ; resistance to amyloid protein A amyloidosis ( Li et al . 2005 ) ; age - related enlargement of lymphoid tissue and altered leukocyte composition ( Wernersson et al . 2009 ) . Hpa Heparanase Null allele : viable ; altered MMP - 2 and MMP - 14 expression ( Zcharia et al . 2009 ) . Sulf1 Endo - 6 - sulfatase 1 Null allele : viable ; esophageal defect ( Ai et al . 2007 ; Ratzka et al . 2008 ) ; enhanced osteoarthritis , MMP - 13 , ADAMTS - 5 , and noggin elevated , col2a1 and aggrecan reduced in cartilage and chondrocytes ( Otsuki et al . 2010 ) . Sulf2 Endo - 6 - sulfatase 2 Null allele : viable ; behavioral defects ( Lamanna et al . 2006 ) ; enhanced osteoarthritis , MMP - 13 , ADAMTS - 5 , and noggin elevated , col2a1 and aggrecan reduced in cartilage and chondrocytes ( Otsuki et al . 2010 ) . Gene trap allele : Sulf2 GT ( pGT1TMpfs ) 155Ska , no phenotype ( Lum et al . 2007 ) . S . Sarrazin et al . 8 Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from A BIRD’S - EYE VIEW OF STRUCTURE AND ASSEMBLY An idealized picture of a HSPG is shown in Figure 2 . Each proteoglycan consists of a protein and one or more covalently attached HS chains . Comprehensive reviews have appeared on the assembly process and structural characteriza - tion of the chains , and therefore these subjects will not be discussed further here ( Esko and Selleck 2002 ; Sugahara and Kitagawa 2002 ; Sasisekharan et al . 2006 ; Ori et al . 2008 ; Lare - more et al . 2009 ) . However , several features are important to consider in the context of their biological activities . ( 1 ) HSPGs are polyani - onic and have unusual hydrodynamic volume because of the presence of long HS chains ( 40 – 300 sugar residues , (cid:2) 20 – 150 nm ) , sulfate groups , and uronic acids . Thus , different HSPGs often copurify by techniques that rely simply on the anionic characteristics of the chains or gel ﬁltration . HS and other sulfated GAGs are amongst the most highly negatively charged biopolymers in nature and variation in the number and length of the chains gives rise to enormous polydispersity . ( 2 ) Some pro - teoglycans contain only one GAG chain ( e . g . , CD44v3 and betaglycan ) , whereas others have Cell – cell cross talk Chemokinepresentation Heparanasecleavage Basementmembraneorganization Barrier formation Storagedepot Proteolyticshedding Cell adhesion and motility Cytoskeletalinteractions Endocytosis Transcellular transport Lysosomaldegradation Secretorygranules HSPG HS Chemokinereceptor Receptortyrosinekinase Integrins Growth factor Chemokine Matrixproteins Lipoprotein Protease Ligand - receptor clustering and signalling ( cis or trans ) Figure 1 . HSPGs have multiple activities in cells and tissues . ( Adapted from Bishop et al . 2007 ; reprinted with permission from Nature Publishing Group # 2007 . ) Heparan Sulfate Proteoglycans Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 9 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from three to ﬁve chains ( e . g . , syndecan ) . Further - more , the stoichiometry of GAG chain substitu - tion can vary depending on source and growth conditions . “Part - time” proteoglycans can exist with or without a GAG chain ( Table 1 ) . ( 3 ) Some proteoglycans contain other types of gly - cans ( e . g . , asparagine - linked [ N - linked ] and ser - ine / threonine - linked [ O - linked ] mucin - type chains ) . Some proteoglycans , such as synde - can - 1 , contain both HS and chondroitin / dermatan sulfate , another type of GAG . Other types of posttranslational modiﬁcations can occur ( e . g . , phosphorylation on cytoplasmic domains of trans - membrane proteoglycans ) . ( 4 ) The number and sulfation state of the chains can vary according to growth conditions and in response to growth factors . ( 5 ) The arrange - ment of negatively charged sulfate groups and the orientation of the carboxyl groups specify the location of ligand - binding sites . Further - more , the sulfated residues are clustered in regions along the chain containing mixtures of iduronic acid and glucuronic acid ( NS do - mains , Fig . 2 ) and are separated by nonsulfated domains rich in glucuronic acid ( NA domains ) . ( 6 ) The pattern of sulfation , extent of uronic NA domain FGFR FGF = GlcNAc = GalNAc = GlcA = Gal = sulfate = Xyl S = IdoA α 4 α 4 α 4 α 4 α 4 α 4 α 4 α 4 α 4 α 4 α 4 α 4 α 4 β 4 β 3 β 3 β 4 β α 4 β 4 β 4 β 4 β 4 Antithrombin Extl3 Ext1Ext2 n Glcat1 Galt2 Xylt1 / 2 Galt1 Coreprotein Hs6st1Hs6st2Hs6st3 Ndst1Ndst2Ndst3Ndst4 6S NS 6S 6S 6S 6S NS NS NS Hs3st1 – 6 Hs2st NS 3S 2S 2S 2S HsGlce NS domain Figure 2 . Heparan sulfate ( HS ) structure . HS biosynthesis initiates by the attachment of xylose to speciﬁc serine residues in HSPG core proteins followed by the formation of a linkage tetrasaccharide , glucuronic acid - galactose - galactose - xylose ( GlcA - Gal - Gal - Xyl ) . Extl3 attaches the ﬁrst N - acetyl - D - glucosamine ( GlcNAc ) resi - due and an enzyme complexcomposed of Ext1 and Ext2 alternatelyadds GlcA and GlcNAc to the nascentchain . The chains simultaneously undergo a series of processing reactions that begins by the removal of the acetyl groups from clusters of GlcNAc residues and substitution of the free amino groups with sulfate , catalyzed by one or more N - deacetylase - N - sulfotransferases ( Ndst ) . The C5 epimerase ( HsGlce ) epimerizes D - glucu - ronic acids immediately adjacent to N - sulfoglucosamine units to L - iduronic acid ( IdoA ) . A series of O - sulfo - transferases can then add sulfate : uronyl 2 - O - sulfotransferase ( Hs2st ) adds sulfate at C2 of the iduronic acids ( and less frequently to glucuronic acids ) , 6 - O - sulfotransferases ( Hs6st1 - 3 ) add sulfate at C6 of the N - sulfoglucosamine units and less frequently to N - acetylglucosamine , and 3 - O - sulfotransferases ( Hs3st1 , 2 , 3a , 3b , 4 , 5 , 6 ) add sulfate at C3 of glucosamine units ( N - sulfated or N - unsubstituted ) . As shown in the top of the ﬁgure by red shading , the modiﬁcations occur in clusters of variable length ( N - sulfated or NS domains ) , which are interspersed by unmodiﬁed domains ( N - acetylated or NA domains ) . The regions at the junction of these domains are sometimes called NA / NS domains ( not shown ) because the extent of processing is less . The modiﬁed domains make up binding sites for protein ligands as depicted for antithrombin , FGF and FGF receptor . The HS chains can be further modiﬁed once they arrive at the cell surface or in the ECM by two endo - sulfatases ( Sulf1 and Sulf2 ) , which remove speciﬁc sulfate groups located at C6 of glucosamine units , or by the action of extracellular heparanase or extracellular proteases ( not shown ) . ( Figure adapted from Bishop et al . 2007 ; reprinted with permission from Nature Publishing Group # 2007 . ) S . Sarrazin et al . 10 Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from acid epimerization , and organization of the modiﬁed residues is generally thought to depend on the cell type in which HS is expressed rather than on the nature of the core protein ( Kato et al . 1994 ) . Thus , the overall composi - tion of HS on different core proteins expressed by the same cell appears to be similar , but great variation occurs between cell types . This con - cept might be an oversimpliﬁcation , as some variation has been suggested to occur in ligand - binding properties and composition dependent on the core protein ( Shworak et al . 1993 ; Tveit et al . 2005 ) . GENERALIZATIONS ABOUT THE INTERACTION OF PROTEIN LIGANDS WITH HS PROTEOGLYCANS HSPGs bind to many ligands , usually via the HS chains . In fact heparin , a highly sulfated form of HS , is often used as an “afﬁnity” matrix for purifying proteins , and many of the growth factors in use today were puriﬁed by heparin af - ﬁnity chromatography . Heparin - binding ligands include growth factors , cytokines , chemokines , enzymes , enzyme inhibitors , and extracellular matrix proteins . In other areas of glycobiology , glycan - binding proteins are referred to as “lectins , ” a designation based on the presence of a carbohydrate recognition domain deﬁned by characteristic protein folds or sequence motifs indicating their membership in an evo - lutionarily conserved gene family ( Varki et al . 2009 ) . In contrast , proteins that bind to HS appear to have evolved by convergent evolution ; that is , they do not possess a speciﬁc fold or recognizable amino acid sequence pattern ( Esko and Linhardt 2009 ) . Heparin - binding sites often occur on the external surface of pro - teins or in shallow grooves lined with positively charged amino acids . Attempts have been made to deﬁne “consensus” sequences in heparin - binding proteins based on content and spacing of positively charged amino acid residues within linear sequences ( Cardin and Weintraub 1989 ; Hileman et al . 1998 ; Capila and Linhardt 2002 ) . However , the binding site for HS is often deﬁned by positive residues contributed by noncontiguous segments of the protein . Although electrostatic interactions contribute much of the binding energy , hydrogen - bond - ing , van der Waal interactions , and hydrophobic effects also participate ( Conrad 1998 ; Capila and Linhardt 2002 ) . The binding of a ligand to HS follows the same principles that underlie the interaction of other macromolecules , but the following considerations are important . † Dissociation constants for HS - dependent ligands range from millimolar to nanomolar values . Many growth factors bind with high afﬁnity ( e . g . , ﬁbroblast growth factors , FGFs ) , whereas many matrix proteins bind with low afﬁnity ( e . g . , ﬁbronectin ) . However , afﬁnity does not dictate selectivity ; some low afﬁnity ligands achieve high avidity through dimerization ( e . g . , chemokines ) or by clus - tering ( e . g . , ﬁbronectin ﬁbrils ) . † The HS chains can facilitate diffusion of ligands by allowing them to bind and slide or dissociate / reassociate through adjacent binding sites ( mass action ) . † Binding can lead to a conformational change in the protein . The best - studied example is the allosteric effect of heparin on anti - thrombin . † HS can act as a template to approximate two proteins next to each other . Antithrombin inactivation of thrombin serves as the para - digm for this type of interaction , but other examples include the association of some growth factors with their receptor tyrosine kinases ( e . g . , FGF with FGF receptors ) . In addition to the HS chains , the protein core of HSPGs can also bind ligands . For exam - ple , the Drosophila glypican ortholog , Dally , can directly interact with a number of morphogens , such as decapentaplegic ( Dpp ) and bone morphogenetic factor 4 , in the absence of HS chains ( Kirkpatrick et al . 2006 ) . Expression of HS - deﬁcient Dally can rescue several mutant phenotypes in Dally - deﬁcient ﬂies , indicating that a number of biologically relevant functions are mediated by the glypican protein core inde - pendently of HS . In mammals , the glypican - 3 Heparan Sulfate Proteoglycans Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 11 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from core protein interacts with hedgehog ( Hh ) independently of HS , and Gpc3 - null embryos display increased Hh signaling , which might explain the overgrowth phenotype observed in patients lacking glypican - 3 ( Simpson – Golabi – Behmel syndrome ) ( Capurro et al . 2008 ) . As discussed below , a peptide sequence in the core protein of syndecan - 1 interacts with a V b 3 and a V b 5 integrins and modulates cell adhesion ( Beauvais et al . 2004 ; McQuade et al . 2006 ) . Finally , perlecan , collagen XVIII , and agrin are large proteins composed of multi - ple , functionally independent domains that can bind to other matrix components and growth factors ( Iozzo et al . 2009 ) . ON THE SPECIFICITY OF BINDING Although some ligands bind directly to the HSPG core proteins , the vast majority interact with sulfated domains within HS chains . Early studies of heparin and its interaction with antithrombin guided much of our thinking about the speciﬁcity of protein – HS interac - tions , but recent studies have broadened our view considerably . Heparin has high antico - agulant activity and higher - than - average overall sulfation ( heparin contains aproximately 2 . 3 sulfate groups per disaccharide , whereas typical HS contains approximately 0 . 8 sulfate groups per disaccharide ) . The anticoagulant properties of heparin , however , do not depend on overall charge , but instead depend on a unique penta - saccharidewith a speciﬁc arrangement of sulfate groups and uronic acid epimers , and requires a sulfate group positioned at C3 of the central glucosamine residue as shown in Figure 2 ( Lin - dahl et al . 1980 ; Atha et al . 1985 ) . This discovery suggested that the interaction of HS with other protein ligands might show similar selectivity . Interestingly , 3 - O - sulfated glucosamine res - idues are quite rare in HS , occurring about 1 / 20 disaccharides in heparin and less than 1 / 100 disaccharides in HS or not at all . Nevertheless , the 3 - O - sulfotransferases comprise the largest familyof HS sulfotransferases , with seven mem - bers ( Fig . 2 ) . Two of the enzymes can produce the antithrombin - binding sequence , whereas the others generate 3 - O - sulfated sequences distinct in structure from the antithrombin - binding site , suggesting their purpose lies in the formation of binding sites for other ligands . One class of these sites interacts with glycopro - tein gD of Herpes simplex virus - 1 and appears to be required for infection ( Shukla et al . 1999 ) . Endogenous ligands include cyclo - philin B ( Vanpouille et al . 2007 ) , FGF7 ( Ye et al . 2001 ) , and possibly the ectodomain of FGFR1 ( McKeehan et al . 1999 ) , but based on the large size of the 3 - O - sulfotransferase family , other ligands undoubtedly exist . Most ligands do not require 3 - O - sulfation , but the study of heparin - antithrombin interac - tion set the stage conceptually for searching for speciﬁc arrangements of sulfated sugars to achieve selective binding . This technically chal - lenging problem was initially approached by fractionating HS into pools that bound to the ligand or that did not , followed by composi - tional analysis or partial sequencing . Unfor - tunately , little variation in composition was noted , most likely because binding sites for most proteins represent only ﬁve to 12 sugars . To circumvent this problem , partially cleaved preparations were employed , eventually leading to the identiﬁcation of minimally sized oligo - saccharides that bound with reasonable afﬁnity and that in some cases would initiate a biologi - cal response . Examples include , but are not limited to , FGF2 ( Guimond et al . 1993 ; Macca - rana et al . 1993 ) , platelet - derived growth factor ( Feyzi et al . 1997 ) , platelet factor 4 ( Maccarana and Lindahl 1993 ; Stringer and Gallagher 1997 ) , MIP1 a ( Stringer et al . 2002 , 2003 ) , he - patocyte growth factor ( scatter factor ) ( Lyon et al . 1994 ; Ashikari et al . 1995 ) , vascular endo - thelial growth factor ( Soker et al . 1994 ; Ono et al . 1999 ; Ashikari - Hada et al . 2005 ; Robinson et al . 2006 ) , lipoprotein lipase ( Parthasarathy et al . 1994 ; Spillmann et al . 2006 ) , amyloid ( Lin - dahl and Lindahl 1997 ) , and L - selectin ( Norgard - Sumnicht and Varki 1995 ; Wang et al . 2002 ) . When FGF1 was studied in detail , it was noted that a range of HS octasaccharides that varied in the number as well as the posi - tions of individual sulfate groups could bind with varying afﬁnity ( Kreuger et al . 2001 ) . Fur - thermore , the formation of complexes between S . Sarrazin et al . 12 Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from FGF1 and FGF receptors was promoted by a variety of saccharides of differing overall sulfate content . This apparent lack of speciﬁcity has a corollary in vivo ; in Drosophila deletion of 2 - O - or 6 - O - sulfotransferases has no effect on FGF signaling and tracheal development , which depends on FGF ( Kamimura et al . 2006 ) . Inac - tivation of either enzyme results in elevated sul - fation at other positions , suggesting a form of molecular compensation . Lack of both enzymes impairs FGF signaling and causes multiple pat - terning deﬁciencies , indicating that HS is essen - tial but that the receptor ligand complex can accommodate differently sulfated oligosacchar - ides . It would appear that other ligand - receptor pairs might behave similarly , because many organs and tissues in mice bearing mutations in these sulfotransferases ( or the epimerase that interconverts glucuronic acid to iduronic acid ) develop normally ( Table 3 ) . Nevertheless , speciﬁcity does exist . For example , mice lacking the 2 - O - sulfotransferase suffer renal agenesis ( Bullock et al . 1998 ) , but other tissues develop normally . In the lacrimal gland , a decrease in overall sulfation of HS affects Fgf10 - Fgfr2b signaling required for branching morphogenesis ( Pan et al . 2008 ) . Similar reduction in overall sulfation alters vasculogenesis ( Jakobsson et al . 2006 ) , tumor angiogenesis ( Fuster et al . 2007 ) , and vascular hyperpermeability ( Xu et al . 2010a ) . Wnt sig - naling is speciﬁcally affected by removal of 6 - O - sulfate groups on HS by a pair of cell surface endolytic - 6 - O - sulfatases ( the Sulfs ) that act at very restricted sites in the chain ( Ai et al . 2003 ; Lamanna et al . 2008 ) . Although the range of biological processes regulated in vivo by the Sulfs remains to be elucidated , growth factors including FGF , Wnt , and GDNF are clearly affected by their loss , resulting in developmen - tal defects and early postnatal lethality ( Ai et al . 2007 ; Holst et al . 2007 ) . Thus , determining whether speciﬁc sequences mediate binding and biological action remains an active area of investigation . Chemokines are a subset of cytokines that interact with HS ( Lortat - Jacob 2009 ) . These small ( 8 – 10 - kDa ) secreted proteins signal through G protein – coupled receptors on cell surfaces to control cell migration in develop - ment , lymphocyte homing , inﬂammation , and wound repair . Binding of chemokinesto HSPGs allows their local retention , protection from degradation ( Sadir et al . 2004 ) , activation by oligomerization ( Proudfoot et al . 2003 ) , and presentation to leukocytes ( Handel et al . 2005 ) . Interestingly , chemokines usually occur as dimers with positively charged domains oriented in different conﬁgurations ( Fig . 3 ) . Although no cocrystal structures are currently available , molecular docking suggests that an HS chain might ﬁt along the dimer interface or can span the heparin - binding domains ori - ented on opposite sides of the dimer . In the lat - ter case , the distance between the two binding sites in the dimer exceeds the length of a typical sulfated domain in HS ( around four to eight sugars ) . Thus , the preferred organization of the bioactive segment of a chain might consist of two short sulfated domains ( NS domains , Fig . 2 ) separated by a nonsulfated linker of a speciﬁc length ( NA domain ) ( Lortat - Jacob et al . 2002 ) . Examples of other ligands in which binding sites require extended or discontinuous domains include IFN - g ( Lortat - Jacob et al . 1995 ) and platelet factor 4 ( Stringer and Gal - lagher 1997 ) , and may include other paired systems , such as FGF / FGFR ( Mulloy and Lin - hardt 2001 ) or VEGF / VEGFR / Nrp1 ( Grune - wald et al . 2010 ) . Generating this arrangement would presumably require spatial control over the assembly process , but how this is achieved in vivo is not known ( Lindahl and Li 2009 ) . PROTEOGLYCANS AS CORECEPTORS In 1991 , Yayon et al . ( 1991 ) and Rapraeger et al . ( 1991 ) reported that cell surface HSPGs facili - tate the formation and signaling of FGF2 - FGF receptor complexes ( Fig . 4A ) . As described above , exogenous heparin or HS can also poten - tiate the formation of complexes of FGF with FGF receptors . In this context , the HSPG or heparin is considered a “coreceptor , ” because its function is to aid the formation of ligand - receptor complexes either through confor - mational change of ligand and / or receptor or by acting as a template to approximate ligand Heparan Sulfate Proteoglycans Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 13 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from and receptor . In cells , activation usually occurs in cis by HSPGs expressed on the same cell as the signaling receptor ( Fig . 4A ) . For example , altering HS sulfation selectively in endothelial cells using the Cre - lox system decreases patho - logical angiogenesis in vivo ( Fuster et al . 2007 ) . Similarly , altering HS in mammary epi - thelial cells has a striking impact on lobuloal - veolar development , in spite of expression of HS in surrounding stromal cells ( Crawford et al . 2010 ) . Studies of lens development ( Pan et al . 2006 ) , branching morphogenesis in the lacrimal gland ( Pan et al . 2008 ; Qu et al . 2011 ) , axon guidance , and development of the central nervous system ( Inatani et al . 2003 ; Yamaguchi et al . 2010 ) also suggest that HSPGs act as coreceptors in acell - autonomous manner . Nevertheless , the observation that exoge - nous heparin , HS or HSPGs can activate FGF signaling raised the possibility that HSPGs on one cell type might activate signaling in trans on adjacent cells . Kraemer and Yost provided the ﬁrst in vivo evidence for trans - activation in their studies of left – right development in Xenopus . In this system ectodermal syndecan - 2 transmits in a non - cell - autonomous fashion IL - 8 K20 K1 R47 H23 R44 K45 K54 K59 K14 K36 K43 K24 K27R41 H18 R60K64 K67 SDF - 1 α RANTES CDF Figure3 . Docking of HS to chemokines . Molecular modeling wasused to dock afullysulfated heparin - like chain toseveralchemokines . Theproteinsarerepresentedby ribbonsexceptfor thesidechainsofthebasic aminoacids directly involved in polysaccharide binding ( green ) . The heparin molecule is represented by sticks . ( Data from Lortat - Jacob et al . 2002 . ) S . Sarrazin et al . 14 Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from left – right information to migrating mesoderm via a growth factor signaling pathway ( Kramer and Yost 2002 ) . More recently , Jacobsson et al . analyzed VEGF signaling in embryoid bodies derived from mutant stem cell populations that were either deﬁcient in HS biosynthesis or in VEGF receptor expression ( Jakobsson et al . 2006 ) . Although both mutant stem cell lines were unable to support VEGF signaling , generation of chimeras restored VEGF signaling and response . A model for how HSPGs might activate VEGF receptors in trans is shown in Figure 4B . As discussed below , germline stem cells are maintained in a stem cell niche by short - range trans - signaling mediated by glypi - cans expressed in niche cells acting on the stem cells ( Hayashi et al . 2009 ) . Trans - activation of receptors by HSPGs could potentially elicit stronger signaling responses by trapping the receptor at the cell surface in an activated state . Overall , the ability of HSPGs to trans - activate adjacent cells represents a novel type of cellular crosstalk and may playan important role in reg - ulating cellular differentiation and response during development . Secreted HSPGs also can act in a non - cell - autonomous manner ( e . g . , by directly eliciting signaling responses in nearby cells ) . The HSPG agrin acts in this way to induce postsynaptic differentiation at the neuromuscular junction ( Bezakova and Ruegg 2003 ) . To carry out this function , agrin is secreted by motor neurons where it activates the receptor muscle - speciﬁc receptor tyrosine kinase ( MuSK ) on adjacent muscle cells . Signaling cascades induced by MuSK signaling result in cytoskeletal reorgan - ization and subsequent aggregation of acetyl - choline receptors on muscle cells , priming the neuromuscular junction for activation . Recent studies have shown that proteolytic processing of agrin at the neurological synapses by neuro - trypsin releases an active carboxy - terminal frag - ment that subsequently induces the formation of dendritic ﬁlopodia on hippocampal neurons ( Matsumoto - Miyai et al . 2009 ) . Other proteo - glycans can also undergo proteolytic process - ing to release bioactive domains that can act in an endocrine fashion , including collagen XVIII ( Marneros and Olsen 2001 ) and perlecan ( Bix and Iozzo 2008 ) . The coreceptor function of some proteo - glycans , such as the trans - membrane syndecans , can be dynamically regulated by modulating their association with the cell surface through a process known as shedding ( Bernﬁeld et al . 1999 ; Manon - Jensen et al . 2010 ) . Syndecan shedding is mediated by matrix metalloprotei - nases ( MMP1 , MMP7 , MMP9 , ADAM17 ) ( Fitzgerald et al . 2000 ; Li et al . 2002 ; Endo et al . 2003 ; Ding et al . 2005 ; Brule et al . 2006 ; P P Trapping in trans Internalization P P P P Internalization Potentiation A B Figure 4 . Model for trans - activation of VEGF receptor by heparan sulfate proteoglycans . ( A ) Resident plasma membrane HSPGs can mediate VEGF interactions with its receptor in cis , inducing cell signaling and sub - sequent internalization of the complex . ( B ) HSPGs from an adjacent cell can also mediate VEGF interactions with its receptor in trans , delaying internalization of the signaling complex and enhancing VEGF response . ( From Jakobsson et al . 2006 ; reprinted with permission from Elsevier # 2006 . ) Heparan Sulfate Proteoglycans Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 15 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from Pruessmeyer et al . 2010 ) . Mechanistically , in - duced shedding of syndecan - 1 appears to involve its cytoplasmic tail , which binds to Rab5 , a small GTPase that regulates intracellular trafﬁcking and signaling events ( Hayashida et al . 2008 ) . Rab5 may regulate shedding by inducing dissociation of syndecan - 1 from b 1 integrin ( see below ) , thus exposing a normally cryptic cleavage site . Shedding has a major effect on the localization and signaling capacity of HS - bound ligands ( Kato et al . 1998 ; Park et al . 2000b ) . Forexample , syndecan - 1 shedding modulates chemokine - dependent inﬂamma - tory processes in models of tissue damage caused by noninfectious agents ( Li et al . 2002 ; Xu et al . 2005b ; Hayashida et al . 2009b ) . Syndecan - 1 shed by implanted tumor cells can exert biologic effects distal to the primary tumor , driving formation of osteoclasts and bone destruction via bound heat - labile factors ( Kelly et al . 2010 ) . Some microorganisms can enhance host cell proteolytic shedding of syndecan - 1 resulting in enhanced bacterial colonization ( Park et al . 2000a , 2001 ) . In all of these models , the activity of shed syndecan ectodomains depends on the HS chains , sug - gesting their activity depends on ligands bound to the chains . PROTEOGLYCANS AS ENDOCYTIC RECEPTORS Although often overlooked , membrane HSPGs also act as endocytic receptors , and undergo constitutive as well as ligand - induced endocy - tosis ( Williams and Fuki 1997 ; Belting 2003 ) . Although the precise mechanism of endocytosis is unclear , it appears to occur independently of clathrin , caveolin , and dynamin , but in a lipid - raft - dependent manner involving vesicles of unusual composition ( Zimmermann et al . 2005 ; Wittrup et al . 2010 ) . Ligands bound to the HS chains “piggy back” into the cell through this route . The endocytic activity of HSPGs plays a signiﬁcant physiological role in lipid metabolism . Recent genetic evidence showed that mice lacking syndecan - 1 accumulate both liver - derived and dietary triglycerides in the form of remnant lipoprotein particles ( Stanford et al . 2009 ) . Altering the structure of HS by selective inactivation of sulfotransferases in hepatocytes led to the same phenotype and showed that the HS chains on syndecan - 1 repre - sent the binding site for the lipoproteins ( Mac - Arthur et al . 2007 ; Stanford et al . 2010 ) . Other membrane HSPGs , such as syndecan - 2 and syndecan - 4 and glypicans , also can medi - ate uptake of ligands in cultured cells ( Fuki et al . 2000 ) . Furthermore , uptake can be induced by FGF2 or by antibody - induced clustering ( Fuki et al . 1997 ; Tkachenko et al . 2004 ; Zimmer - mann et al . 2005 ) . Although recycling of inter - nalized HSPGs has been observed ( Fransson et al . 1995 ; Zimmermann et al . 2005 ) , most HSPGs end up in lysosomes , where they undergo degradation by lysosomal proteases and exolytic glycosidases and sulfatases . Bound ligands also are degraded , which provides a mechanism for delivering nutrients to cells or for removal of bioactive factors from the environment . The formation of tissue gradients of morphogens ( discussed below ) may depend in part on continuous clearance of the ligands through an endocytic mechanism ( Lander et al . 2002 ; Marois et al . 2006 ; Ren et al . 2009 ) . Viruses and other pathogens can exploit HSPGs to transit from the extracellular envi - ronment to the inside of cells . The membrane - penetrating peptide , HIV - tat , is released from HIV - infected cells and then enters surrounding cells using HSPGs ( Green and Loewenstein 1988 ; Frankel and Pabo 1988 ) . Based in part on HIV - tat , a number of cell - penetrating - peptides have been generated , typically rich in arginine or lysine residues that will facilitate interaction with HSPGs ( Poon and Gariepy 2007 ) . In addition , synthetic positively charged transporters , such as guanidinylated amino - glycosides have been prepared . Conjugation of these carriers to drugs , toxins , enzymes , oligo - nucleotides , as well as quantum dots can medi - ate delivery of cargo into the cells via HSPGs ( Elson - Schwab et al . 2007 ; Sarrazin et al . 2010 ) . HSPGs can also mediate transcellular trans - port . Wang et al . showed HSPG - mediated che - mokine transport across endothelial cells and its dependence on the sulfation state of the HS chains ( Wang et al . 2005 ) . As discussed below , S . Sarrazin et al . 16 Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from cell surface HSPGs are also engaged in cell adhe - sion , which is dependent on the interaction of HS chains with ECM proteins such as ﬁbronec - tin . Whether cell attachment and endocytosis are mutually exclusive or perhaps mediated through different membrane proteoglycans is unclear . PROTEOGLYCANS AS ADHESION RECEPTORS HSPGs play several roles in cell adhesion and in the determination of cell shape . These pro - cesses depend on binding of cell surface HS to “heparin - binding” domains present in matrix proteins , such as ﬁbronectin , laminins , vitronectin , thrombospondin , and some ﬁbril - lar collagens ( Bernﬁeld et al . 1999 ) . Syndecan - 4 provides an interesting example of a mechan - ical and functional link between the ECM and the actin cytoskeleton . Syndecan - 4 is widely expressed during development and in most adult tissues and is a central component of focal adhesions ( Oh and Couchman 2004 ) . Fibroblasts lacking syndecan - 4 have an altered actin cytoskeleton and multiple HS chains are required to cluster syndecan - 4 on the plasma membrane ( Gopal et al . 2010 ) . Consistent with this idea , overexpression of syndecan - 4 in CHO cells results in increased focal adhesion formation , organization of cytoskeletal stress ﬁbers , and decreased cell motility ( Longley et al . 1999 ) . The activity of syndecan - 4 depends on multimerization , which occurs via recruit - ment of PIP 2 , activation of PKC - a , and down - stream signaling through the RhoA pathway ( Oh et al . 1997a , b , c ) . Interestingly , multi - merization of syndecan - 4 is prevented by phos - phorylation of its cytoplasmic tail by PKC - d in response to FGF2 signaling ( Murakami et al . 2002 ) . FGF2 is a mitogen and during prolif - eration , cells need to detach to undergo cyto - kinesis . Thus , syndecan - 4 has a central role in coordinating cytoskeletal changes that take place during adhesion and cell proliferation . As described in other articles ( e . g . , Schwartz 2010 ; Campbell and Humphries 2011 ; Geiger and Yamada 2011 ; Watt and Fujiwara 2011 ) , integrins mediate various interactions between cells and ECM components . Integrins can rec - ognize short peptide sequences ( e . g . , RGD ) present in many ECM proteins , and binding leads to activation , intracellular signaling via kinases and other enzymes , and focal adhesion formation ( Cox et al . 2006 ) . When ﬁbroblasts attach and spread in response to ﬁbronectin fragments containing the RGD site , the forma - tion of focal adhesions and stress ﬁbers can often take place only if the heparin - binding domain of the ﬁbronectin is also present ( Saon - cella et al . 1999 ; Woods et al . 2000 ; Morgan et al . 2007 ) . The HS chains of syndecan - 4 bind to ﬁbronectin , which together with integrin , induce formation of focal adhesions and stress ﬁbers ( Fig . 5 ) . Syndecan - 1 ( and syndecan - 4 ) also can reg - ulate activation of a v b 3 and a v b 5 integrin by way of interaction of the extracellular domain of the proteoglycan with the b - integrin subunit ( Beauvais et al . 2004 , 2009 ; McQuade et al . 2006 ) . The engagement of these receptors occurs outside the cell via a deﬁned peptide segment in syndecan - 1 , but the activation mechanism is cytoplasmic and occurs via a talin - dependent , inside - out signaling pathway that requires syndecan - 1 clustering . The HS chains of syndecan - 1 are required , presumably by facilitating syndecan - 1 clustering along aggregated ECM components . HSPGs also can facilitate cell – cell adhesion . During the inﬂammatory response , endothelial HS interacts with L - selectin on passing leuko - cytes to aid in the initial tethering of leukocytes to the lumenal surface of the endothelium ( Wang et al . 2005 ; Celie et al . 2009 ) . This inter - action may depend on the presence of an unusual N - unsubstituted glucosamine unit in HS ( Norgard - Sumnicht and Varki 1995 ) per - haps in combination with fully sulfated domains ( Smits et al . 2010 ) . Interestingly , heparinoids administered intravenously to mice dramatically reduce leukocyte inﬁltration in response to inﬂammation ( Wang et al . 2002 ) by disruption of endogenous HS - selectin ( Wang et al . 2005 ) or sialyl Lewis a / x - selectin interactions ( Koenig et al . 1998 ; Stevenson et al . 2007 ) . After passing the endothelial cell layer , leucocytes encounter the vascular Heparan Sulfate Proteoglycans Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 17 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from basement membrane . Leukocyte migration through this barrier is considered to involve local degradation by matrix metalloproteinases and secreted heparanase , which may be neces - sary for dissolution of HSPG in the basement membrane ( Vreys and David 2007 ; Li and Vlo - davsky 2009 ) . PROTEOGLYCANS REGULATE GROWTH FACTOR BINDING TO ECM AND CELL MIGRATION The ECM provides a structural network for mediating and regulating cellular movement ( e . g . , during development and wound repair ) . One of the ways the ECM regulates cell migra - tion is to directly bind growth factors , such as platelet - derived growth factor ( PDGF ) , provid - ing directional and stimulatory cues for moving cells ( Smith et al . 2009 ) . Interestingly , the as - sociation of PDGF with ECM appears to be dependent on HS , but does not involve direct binding to HS ( Symes et al . 2010 ) . Similarly , HS - dependent interactions between ﬁbronectin and VEGF have been reported ( Mitsi et al . 2006 ) . The mechanism by which HS regulates the binding of growth factors to ﬁbronectin appears to stem from its ability to induce the transition of ﬁbronectin from a globular form to a more stable extended form , revealing growth factor – binding sites ( Mitsi et al . 2008 ) . This activity depends on the size and composi - tion of the chains , as shown by studies in which only heparin chains longer than 22 saccharides and with sulfation at the 6 - O - and N - positions of glucosamine units retained the ability to modify ﬁbronectin structure and allow VEGF binding ( Mitsi et al . 2006 ) . Tissue - speciﬁc expression of different pro - teoglycans during zebraﬁsh embryogenesis also has been shown to play a role in determin - ing the structure and function of the extra - cellular matrix . Syndecan - 2 expression in the extraembryonic yolk syncytial layer induces ﬁbronectin and laminin matrix assembly throughout the embryo and directs primordial cell migration ( Arrington and Yost 2009 ) . Inter - estingly , overexpression of syndecan - 2 in the embryo does not rescue embryonic defects resulting from yolk syncytial layer deﬁciency , suggesting that proteoglycans in speciﬁc cell types can act in a unique manner because of either positional or structural differences . Other studies have also shown that the loss of speciﬁc proteoglycans such as syndecan - 4 in Xenopus laevis can have adverse effects on neural crest cell migration ( Matthews et al . 2008 ) and con - vergent extension movements ( Munoz et al . 2006 ) . These model systems provide a powerful empirical approach for determining the partic - ipation of HSPGs in matrix deposition and cell migration . Figure 5 . The role of syndecan - 4 in focal adhesion . ( A ) Fibroblasts attach and spread through a 5 b 1 integrin on coverslips coated with the integrin - binding domain of ﬁbronectin but they do not form focal adhesions . ( B ) Focal adhesions ( arrows ) form onlyafterengagement of syndecan - 4 HS chains after the addition of the heparin - binding domain ( HepII ) from ﬁbronectin . ( Data for image from Okina et al . 2009 . ) S . Sarrazin et al . 18 Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from PROTEOGLYCANS AND BARRIER ACTIVITY HSPGs were long thought to be a ﬁltration bar - rier for charged macromolecules in the kidney , but recent studies cast doubt on this idea . The basement membrane of the kidney ﬁltration structure , the glomerulus , contains HSPGs such as agrin , perlecan , and collagen XVIII , and HS accounts for much of the negative charge in the glomerular basement membrane ( GBM ) ( Miner 1999 ; Raats et al . 2000 ) . Early studies in which HS was removed by perfusion of rat kidneys with heparinase suggested that HS was essential for ﬁltration of large charged proteins such as ferritin and albumin ( Kanwar et al . 1980 ) . Correlations of reduced HS levels in the GBM , increased heparanase expression and proteinuria were also made in patients with various kidney diseases such as diabetic nephropathy , further suggesting a putative bar - rier function for GBM HS ( Makino et al . 1992 ; Tamsma et al . 1994 ; van den Hoven et al . 2006 ; Wijnhoven et al . 2006 ) . However , confusion arose when subsequent in vivo studies failed to substantiate that removal of GBM HS with heparinase can result in acute proteinuria , and in fact enzyme digestion actually prevented proteinuria induced by removal of sialic acids ( Wijnhoven et al . 2007a , b ) . Furthermore , tissue - speciﬁc deletion of the major GBM HSPGs in mice does not cause proteinuria ( Rossi et al . 2003 ; Harvey et al . 2007 ; Goldberg et al . 2009 ) , nor does complete ablation of HS biosynthesis in mouse podocytes until 8 months of agewhen proximal tubule abnormal - ities become prevalent ( Chen et al . 2008 ) . Taken together , it appears that the actual function of HS in the glomerulus is associated with its con - trol of podocyte behavior and not as an ultraﬁl - tration barrier . Although HSPGs do not appear to play a substantial role in permselectivity in the kidney , cell surface HSPGs of the syndecan family have been shown to play a major role in maintaining the barrier integrity of the intestinal epithelium ( Bode et al . 2006 , 2008 ) . The loss of syndecan - 1 or its GAG chains from the intestinal epithe - lium has been shown to correlate with an efﬂux of plasma proteins into the intestinal lumen , causing a potentially lethal condition known as protein - losing enteropathy ( PLE ) ( Murch et al . 1993 , 1996 ; Westphal et al . 2000 ) . The relationship between loss of syndecan - 1 and PLE appears to be because of the ability of syndecan - 1 to down - regulate inﬂammatory cytokines , such as IFN - g and TNF - a , which work together to disrupt interepithelial integ - rity . Thus , it is thought that loss of syndecan - 1 or its HS chains in the intestine exposes the epithelium to cytokine insult , resulting in the disruption of cell – cell interactions and PLE ( Bode et al . 2008 ) . Syndecan - 1 may play a direct role in sealing the gaps between intestinal epithelial cells , acting as a physical barrier to prevent protein leakage ( Bode et al . 2008 ) . Importantly , the administration of nonantico - agulant heparin to syndecan - 1 - deﬁcient mice as well as to one patient with PLE has proven effective at correcting protein leakage ( Bode et al . 2008 ; Liem et al . 2008 ) , suggesting that patients suffering from barrier dysfunction dis - eases associated with HSPG deﬁciency could be treated similarly . MORPHOGEN AND CHEMOKINE GRADIENTS Morphogens are signaling molecules that are expressed in restricted regions of tissue and can form gradients that specify cellular dif - ferentiation and patterning during develop - ment . Studies of morphogen diffusion in the Drosophila wing disk have shown that some morphogens , such as wingless ( Wg ) , hedgehog ( Hh ) and Dpp , require HS for effective diffu - sion and will not cross cellular regions deﬁcient in HS ( Jackson et al . 1997 ; The et al . 1999 ; Tsuda et al . 1999 ; Baeg et al . 2001 ; Bornemann et al . 2004 ) . Similar studies in the Drosophila wing disc revealed that glypicans are essential for morphogen diffusion ( Belenkaya et al . 2004 ; Han et al . 2005 ; Yan and Lin 2009 ) . These ﬁnd - ings suggest a model of morphogen mobility known as restricted diffusion , where morpho - gens are transferred from one HSPG to the next at the cell surface , moving from regions of high concentration to regions of low concen - tration along a path that is deﬁned by the Heparan Sulfate Proteoglycans Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 19 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from interacting ligand ( Yan and Lin 2009 ) . Although this model might describe the mechanism by which HSPGs regulate short - range morphogen gradients , other modes of morphogen trans - mission are thought to exist . For example , in studies ofmorphogendiffusioninthe Drosophila wing disc , Eaton and colleagues have described exocellular vesicles ( argosomes ) and lipoprotein particles ( Lipophorin ) that can mediate the transmission of morphogens over long distances ( Greco et al . 2001 ; Eugster et al . 2007 ) . Interest - ingly , the packaging of morphogens , such as Wg into argosomes , is HS - dependent and membrane - associated glypicans can recruit Lip - ophorin containing lipid - modiﬁed forms of Hh and Wg to disc tissue . Lander has discussed in detail the complexity of factors that can affect the shape of morphogen gradients and other ways that HSPGs participate in this process ( Lander et al . 2002 ; Lander 2007 ) . Glypicans may play an important role in morphogen gradient formation because of their mode of attachment to the cell surface . Unlike other proteoglycans , glypicans are bound to the cell membrane via a GPI anchor , allowing diffusion to occur in the outer leaﬂet of the plasma membrane and afﬁliation with speciﬁc membrane structures such as lipid rafts ( Taylor et al . 2009 ; Gutierrez and Brandan 2010 ) . The ability of glypicans to localize into lipid rafts may allow them to associate more directly with a number of morphogens , such as Hh and Wg , which are themselves lipidated ( Rietveld et al . 1999 ; Zhai et al . 2004 ) . It is also interesting to note that the GPI anchor of glypicans can be cleaved from the cell surface by the hydrolase Notum ( Kirkpatrick et al . 2004 ; Kreuger et al . 2004 ) , a process that may impact the ability of these proteoglycans to regulate morphogen gradients . In support of this idea , overexpression of a secreted form of glypican that lacks a GPI anchor dramatically expands the range of the Hh activity in the Drosophila wing disc ( Takeo et al . 2005 ) . The reason for this expansion is unclear , but may be caused by a stabilizing effect of this secreted proteoglycan on Hh as it diffuses from its source . Alternatively , secreted glypican may interfere with Hh posttranslational processing events , such as cholesterol modiﬁcation . HSPGs can modulate morphogen mobility by promot - ing their association with modiﬁer enzymes such as ADAMs ( a disintegrin and metallopro - teinases ) and transglutaminases ( Dierker et al . 2009a , b ) . Whether the ability of HSPGs to mediate restricted diffusion and morphogen modiﬁcation represents distinct mechanisms for the control of gradients is currently unclear . One should also keep in mind that many other factors diffuse through the ECM en route to their ﬁnal destinations and therefore would encounter HSPGs on the surfaces of cells , in the interstitial matrix or in a basement mem - brane . For example , lipoprotein lipase is ex - pressed by adipocytes and skeletal and cardiac myocytes , but its site of action is on the lumenal side of the capillary endothelium in resident blood vessels . A recent study has shown that deletion of collagen XVIII results in chylomi - cronemia caused by decreased presentation of the lipase in the vasculature ( Bishop et al . 2010 ) . Because deﬁciency of collagen XVIII causes thickening of basement membranes ( Utriainen et al . 2004 ) , the decreased presenta - tion of the lipase might be caused by delayed diffusion through the basement membrane underlying capillaries in tissues involved in li - polysis . Plasma lipids are normal in perlecan mutants lacking the HS attachment sites ( Tran - Lundmark et al . 2008 ; Bishop et al . 2010 ) , indi - cating speciﬁcity might exist in the interaction of the lipase with HSPGs in the matrix . STEM CELL NICHE The generation , maintenance and repair of dif - ferent tissues during development is regulated by stem cell populations that reside in deﬁned cellular microenvironments known as stem cell niches . These niches are essential for determining the ability of stem cells to retain a self - perpetuating pluripotent state or to differ - entiate into committed tissue speciﬁc progeni - tors ( Nurcombe and Cool 2007 ) . Interestingly , many of the signaling molecules involved in stem cell maintenance , such as Wnts and FGFs , are regulated by HSPGs ( Sato et al . 2004 ; Xu et al . 2005a , c ) . Furthermore , embryonic S . Sarrazin et al . 20 Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from stem cells change the structure of their HS as they differentiate into speciﬁc lineages ( John - son et al . 2007 ; Baldwin et al . 2008 ) . To directly address the role of HSPGs in stem cell differentiation , mouse embryonic stem cells with mutations in HS biosynthesis have been studied . Embryonic stem cells that lack HS because of Ext1 gene deﬁciency are incapable of differentiation on removal of leukemia inhibitory factor , apparently caused by a defective response to FGF ( Kraushaar et al . 2010 ) . These ﬁndings were corroborated by studies in embryonic stem cells lacking Ndst1 / 2 , which also cannot differentiate in response to FGF because of reduced sulfation ( Lanner et al . 2010 ) . In addition , mouse embry - onic stem cells deﬁcient in Ndst1 / 2 were found to be unable to respond to VEGF , preventing their differentiation into blood capillary struc - tures ( Jakobsson et al . 2006 ) . Taken together , these studies substantiate the importance of HS in stem cell differentiation at least ex vivo . To address how HSPGs might regulate stem cells in their native cellular environments , Nakato and colleagues examined whether glypi - can participated in the maintenance of stem cells in the Drosophila germline stem cell niche . Interestingly , this function appears to be related to the ability of glypicans to restrict the localization and activity of the morphogen Dpp to the outer boundary of the niche ( Haya - shi et al . 2009 ) . Stem cells directly adjacent to this Dpp - rich pocket were shown to be activated in trans by this morphogen and remained plu - ripotent . Daughter cells that were not able to physically associate with this region remained resistant to Dpp signaling and subsequently underwent differentiation . These ﬁndings will likely have important implications for stem - cell - based treatments of disease and for the design of synthetic matrices for stem - cell - based tissue engineering . CONCLUDING REMARKS The purpose of this article was to provide an overview of HSPGs and their biological roles in the ECM . As described above , HSPGs bind many ligands , modulate numerous cellular activities , and aid in tissue architecture and physiology . The examples selected for presenta - tion represent only a subset of activities associ - ated with HSPGs . However , it is striking that so many essential activities appear to be regu - lated by such a small family of macromolecules . Understanding how cells regulate the expression and composition of HSPGs to achieve these diverse activities in a coordinated fashion is a major biological problem to solve . The problem may be as complex as unraveling the genetic code , given the enormous complexity of hep - aran sulfate . ACKNOWLEDGMENTS The authors acknowledge grants GM33063 and HL57345 ( to J . D . E ) and F32DK085905 ( to W . C . L ) from the National Institutes of Health and a grant from Fondation pour la Recherche Medicale ( to S . S . ) . REFERENCES AbrinkM , GrujicM , PejlerG . 2004 . Serglycinisessentialfor maturation of mast cell secretory granule . J Biol Chem 279 : 40897 – 40905 . Adhikari N , Basi DL , Townsend D , Rusch M , Mariash A , Mullegama S , Watson A , Larson J , Tan S , Lerman B , et al . 2010 . Heparan sulfate Ndst1 regulates vascular smooth muscle cell proliferation , vessel size and vascular remodeling . J Mol Cell Cardiol 49 : 287 – 293 . Ai X , Do AT , Lozynska O , Kusche - Gullberg M , Lindahl U , Emerson CP Jr . 2003 . QSulf1 remodels the 6 - O sulfation states of cell surface heparan sulfate proteo - glycans to promote Wnt signaling . J Cell Biol 162 : 341 – 351 . Ai X , Kitazawa T , Do AT , Kusche - Gullberg M , Labosky PA , Emerson CP Jr . 2007 . SULF1 and SULF2 regulate hep - aran sulfate - mediated GDNF signaling for esophageal innervation . Development 134 : 3327 – 3338 . AikawaT , WhippleCA , LopezME , GunnJ , YoungA , Lander AD , Korc M . 2008 . Glypican - 1 modulatesthe angiogenic and metastatic potential of human and mouse cancer cells . J Clin Invest 118 : 89 – 99 . Arikawa - Hirasawa E , Watanabe H , Takami H , Hassell JR , Yamada Y . 1999 . Perlecan is essential for cartilage and cephalic development . Nat Genet 23 : 354 – 358 . Arikawa - Hirasawa E , Wilcox WR , Le AH , Silverman N , Govindraj P , Hassell JR , Yamada Y . 2001 . Dyssegmental dysplasia , Silverman – Handmaker type , is caused by functionalnullmutationsoftheperlecangene . NatGenet 27 : 431 – 434 . Arikawa - Hirasawa E , Rossi SG , Rotundo RL , Yamada Y . 2002 . Absence of acetylcholinesterase at the neuromuscular Heparan Sulfate Proteoglycans Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 21 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from junctions of perlecan - null mice . Nature Neurosci 5 : 119 – 123 . Arrington CB , Yost HJ . 2009 . Extra - embryonic syndecan 2 regulates organ primordia migration and ﬁbrillogenesis throughout the zebraﬁsh embryo . Development 136 : 3143 – 3152 . Ashikari S , Habuchi H , Kimata K . 1995 . Characterization of heparan sulfate oligosaccharides that bind to hepatocyte growth factor . J Biol Chem 270 : 29586 – 29593 . Ashikari - Hada S , Habuchi H , Kariya Y , Kimata K . 2005 . Heparin regulates vascular endothelial growth factor 165 - dependent mitogenic activity , tube formation , and its receptor phosphorylation of human endothelial cells . Comparison of the effects of heparin and modiﬁed heparins . J Biol Chem 280 : 31508 – 31515 . Atha DH , Lormeau JC , Petitou M , Rosenberg RD , Choay J . 1985 . Contribution of monosaccharide residues in heparin binding to antithrombin III . Biochemistry 24 : 6723 – 6729 . Baeg GH , Lin X , Khare N , Baumgartner S , Perrimon N . 2001 . Heparan sulfate proteoglycans are critical for the organizationoftheextracellulardistributionofWingless . Development 128 : 87 – 94 . BaldwinRJ , tenDamGB , vanKuppeveltTH , LacaudG , Gal - lagherJT , KouskoffV , MerryCL . 2008 . Adevelopmentally regulated heparan sulfate epitope deﬁnes a subpopula - tion with increased blood potential during mesodermal differentiation . Stem Cells 26 : 3108 – 3118 . Bao X , Moseman EA , Saito H , Petryanik B , Thiriot A , Hata - keyama S , Ito Y , Kawashima H , Yamaguchi Y , Lowe JB , et al . 2010 . Endothelial heparan sulfate controls chemo - kine presentation in recruitment of lymphocytes and dendritic cells to lymph nodes . Immunity 33 : 817 – 829 . Bass MD , Roach KA , Morgan MR , Mostafavi - Pour Z , Schoen T , Muramatsu T , Mayer U , Ballestrem C , Spatz JP , Humphries MJ . 2007 . Syndecan - 4 - dependent Rac1 regulation determines directional migration in response to the extracellular matrix . J Cell Biol 177 : 527 – 538 . Beauvais DM , Burbach BJ , Rapraeger AC . 2004 . The syndecan - 1 ectodomain regulates a v b 3 integrin activity in human mammary carcinoma cells . J Cell Biol 167 : 171 – 181 . Beauvais DM , Ell BJ , McWhorter AR , Rapraeger AC . 2009 . Syndecan - 1 regulates a v b 3 and a v b 5 integrin activation during angiogenesis and is blocked by synstatin , a novel peptide inhibitor . J Exp Med 206 : 691 – 705 . Beiting DP , Park PW , Appleton JA . 2006 . Synthesis of syndecan - 1 by skeletal muscle cells is an early response to infection with Trichinella spiralis but is not essential fornursecelldevelopment . InfectImmun 74 : 1941 – 1943 . BelenkayaTY , Han C , YanD , OpokaRJ , KhodounM , Liu H , Lin X . 2004 . Drosophila Dpp morphogen movement is independent of dynamin - mediated endocytosis but regulated by the glypican members of heparan sulfate proteoglycans . Cell 119 : 231 – 244 . Bellaiche Y , The I , Perrimon N . 1998 . Tout - velu is a Droso - phila homologue of the putative tumour suppressor EXT - 1 and is needed for Hh diffusion . Nature 394 : 85 – 88 . Belting M . 2003 . Heparan sulfate proteoglycan as a plasma membrane carrier . Trends Biochem Sci 28 : 145 – 151 . Bernﬁeld M , Gotte M , Park PW , Reizes O , Fitzgerald ML , Lincecum J , Zako M . 1999 . Functions of cell surface heparan sulfate proteoglycans . Annu Rev Biochem 68 : 729 – 777 . Bezakova G , Ruegg MA . 2003 . New insights into the roles of agrin . Nat Rev Mol Cell Biol 4 : 295 – 308 . Bhanot P . 2002 . Plasmodium yoelii sporozoites infect syndecan - 1 deﬁcient mice . Molec Biochem Parasitol 123 : 143 – 144 . Bishop JR , Schuksz M , Esko JD . 2007 . Heparan sulphate proteoglycans ﬁne - tune mammalian physiology . Nature 446 : 1030 – 1037 . Bishop JR , Passos - Bueno MR , Fong L , Stanford KI , Gon - zales JC , Yeh E , Young SG , Bensadoun A , Witztum JL , Esko JD , et al . 2010 . Deletion of the basement membrane heparan sulfate proteoglycan type XVIII collagen causes hypertriglyceridemia in mice and humans . PLoS ONE 5 : e13919 . Bix G , Iozzo RV . 2008 . Novel interactions of perlecan : Unraveling perlecan’s role in angiogenesis . Microsc Res Tech 71 : 339 – 348 . Bode L , Murch S , Freeze HH . 2006 . Heparan sulfate plays a central role in a dynamicinvitro model of protein - losing enteropathy . J Biol Chem 281 : 7809 – 7815 . Bode L , Salvestrini C , Park PW , Li JP , Esko JD , Yamaguchi Y , Murch S , Freeze HH . 2008 . Heparan sulfate and syndecan - 1 are essential in maintaining murine and human intestinal epithelial barrier function . J Clin Invest 118 : 229 – 238 . Bornemann DJ , Duncan JE , Staatz W , Selleck S , Warrior R . 2004 . Abrogation of heparan sulfate synthesis in Droso - phila disrupts the Wingless , Hedgehog and Decapenta - plegic signaling pathways . Development 131 : 1927 – 1938 . Boyanovsky BB , Shridas P , Simons M , van der Westhuyzen DR , Webb NR . 2009 . Syndecan - 4 mediates macrophage uptake of group V secretory phospholipase A2 - modiﬁed LDL . J Lipid Res 50 : 641 – 650 . BruleS , CharnauxN , SuttonA , LedouxD , ChaigneauT , Saf - far L , Gattegno L . 2006 . The shedding of syndecan - 4 and syndecan - 1 from HeLa cells and human primary macro - phages is accelerated by SDF - 1 / CXCL12 and mediated by the matrix metalloproteinase - 9 . Glycobiology 16 : 488 – 501 . Bullock SL , Fletcher JM , Beddington RS , Wilson VA . 1998 . Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2 - sulfo - transferase . Genes Dev 12 : 1894 – 1906 . Bulow HE , Hobert O . 2006 . The molecular diversity of gly - cosaminoglycans shapes animal development . Annu Rev Cell Dev Biol 22 : 375 – 407 . Campbell ID , Humphries MJ . 2011 . Integrin structure , acti - vation , andinteractions . ColdSpring HarbPerspectBiol 3 : a004994 . Campos - Xavier AB , Martinet D , Bateman J , Belluoccio D , RowleyL , TanTY , BaxovaA , GustavsonKH , Borochowitz ZU , Innes AM , et al . 2009 . Mutations in the heparan - sulfate proteoglycan glypican 6 ( GPC6 ) impair endo - chondral ossiﬁcation and cause recessive omodysplasia . Am J Hum Genet 84 : 760 – 770 . Cano - GauciDF , SongHH , YangH , McKerlieC , ChooB , Shi W , Pullano R , Piscione TD , Grisaru S , Soon S , et al . S . Sarrazin et al . 22 Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from 1999 . Glypican - 3 - deﬁcient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson – Golabi – Behmel syndrome . J Cell Biol 146 : 255 – 264 . Capila I , Linhardt RJ . 2002 . Heparin - protein interactions . Angew Chem Int Edit 41 : 391 – 412 . Capurro MI , Xu P , Shi W , Li F , Jia A , Filmus J . 2008 . Glypican - 3 inhibits Hedgehog signaling during develop - ment by competing with patched for Hedgehog binding . Dev Cell 14 : 700 – 711 . Cardin AD , Weintraub HJ . 1989 . Molecular modeling of protein – glycosaminoglycan interactions . Arteriosclerosis 9 : 21 – 32 . Celie JW , Rutjes NW , Keuning ED , Soininen R , Heljasvaara R , Pihlajaniemi T , Drager AM , Zweegman S , Kessler FL , Beelen RH , et al . 2007 . Subendothelial heparan sulfate proteoglycans become major L - selectin and monocyte chemoattractant protein - 1 ligands upon renal ische - mia / reperfusion . Am J Pathol 170 : 1865 – 1878 . Celie JW , Beelen RH , van den Born J . 2009 . Heparan sulfate proteoglycans in extravasation : assisting leukocyte guid - ance . Front Biosci 14 : 4932 – 4949 . Cevikbas F , Schaefer L , Uhlig P , Robenek H , Theilmeier G , EchtermeyerF , Bruckner P . 2008 . Unilateralnephrectomy leads to up - regulation of syndecan - 2 - and TGF - b - medi - ated glomerulosclerosis in syndecan - 4 deﬁcient male mice . Matrix Biol 27 : 42 – 52 . Chen E , Stringer SE , Rusch MA , Selleck SB , Ekker SC . 2005 . Aunique role for 6 - O sulfation modiﬁcation in zebraﬁsh vascular development . Dev Biol 284 : 364 – 376 . Chen S , Wassenhove - McCarthy DJ , Yamaguchi Y , Holzman LB , van Kuppevelt TH , Jenniskens GJ , Wijnhoven TJ , Woods AC , McCarthy KJ . 2008 . Loss of heparan sulfate glycosaminoglycan assembly in podocytes does not lead to proteinuria . Kidney Int 74 : 289 – 299 . Chiao E , Fisher P , Crisponi L , Deiana M , Dragatsis I , Schles - singer D , Pilia G , Efstratiadis A . 2002 . Overgrowth of a mouse model of the Simpson – Golabi – Behmel syn - drome is independent of IGF signaling . Dev Biol 243 : 185 – 206 . Condac E , Silasi - Mansat R , Kosanke S , Schoeb T , Towner R , Lupu F , Cummings RD , Hinsdale ME . 2007 . Polycystic disease caused by deﬁciency in xylosyltransferase 2 , an initiating enzyme of glycosaminoglycan biosynthesis . Proc Natl Acad Sci 104 : 9416 – 9421 . ConradHE . 1998 . Heparin - bindingproteins AcademicPress , San Diego . Cornelison DDW , Wilcox - Adelman SA , Goetinck PF , Rau - valaH , RapraegerAC , OlwinBB . 2004 . Essentialandsep - arable roles for Syndecan - 3 and Syndecan - 4 in skeletal muscle development and regeneration . Genes Dev 18 : 2231 – 2236 . Costell M , Carmona R , Gustafsson E , Gonza´lez - Iriarte M , Fa¨ssler R , Mun˜oz - Cha´puli R . 2002 . Hyperplastic cono - truncal endocardial cushions and transposition of great arteries in perlecan - null mice . Circ Res 91 : 158 – 164 . Couchman JR . 2010 . Transmembrane signaling proteogly - cans . Annu Rev Cell Dev Biol 26 : 89 – 114 . Cox BD , Natarajan M , Stettner MR , Gladson CL . 2006 . New concepts regarding focal adhesion kinase promotion of cell migration and proliferation . J Cell Biochem 99 : 35 – 52 . Crawford BE , Garner OB , Bishop JR , Zhang DY , Bush KT , NigamSK , Esko JD . 2010 . Loss oftheheparansulfatesul - fotransferase , Ndst1 , in mammary epithelial cells selec - tively blocks lobuloalveolar development in mice . PLoS ONE 5 : e10691 . DanielsonKG , Martinez - HernandezA , HassellJR , IozzoRV . 1992 . Establishment of a cell line from the EHS tumor : Biosynthesis of basement membrane constituents and characterization of a hybrid proteoglycan containing heparan and chondroitin sulfate chains . Matrix 11 : 22 – 35 . Dierker T , Dreier R , Migone M , Hamer S , Grobe K . 2009a . Heparan sulfate and transglutaminase activity are required for the formation of covalently cross - linked hedgehog oligomers . J Biol Chem 284 : 32562 – 32571 . Dierker T , Dreier R , PetersenA , Bordych C , Grobe K . 2009b . Heparan sulfate – modulated , metalloprotease - mediated sonic hedgehog release from producing cells . J Biol Chem 284 : 8013 – 8022 . Ding K , Lopez - Burks M , Sanchez - Duran JA , Korc M , Lander AD . 2005 . Growth factor – induced shedding of syndecan - 1confers glypican - 1dependence on mitogenic responses of cancer cells . J Cell Biol 171 : 729 – 738 . Echtermeyer F , Streit M , Wilcox - Adelman S , Saoncella S , Denhez F , Detmar M , Goetinck P . 2001 . Delayed wound repair and impaired angiogenesis in mice lacking syndecan - 4 . J Clin Invest 107 : 9 – 14 . Echtermeyer F , Bertrand J , Dreier R , Meinecke I , Neugeba - uer K , Fuerst M , Lee YJ , Song YW , Herzog C , Theilmeier G , et al . 2009 . Syndecan - 4 regulates ADAMTS - 5 activa - tion and cartilage breakdown in osteoarthritis . Nat Med 15 : 1072 – 1076 . EdovitskyE , Lerner I , ZchariaE , PeretzT , VlodavskyI , Elkin M . 2006 . Role of endothelial heparanase in delayed - type hypersensitivity . Blood 107 : 3609 – 3616 . Elson - SchwabL , GarnerOB , SchukszM , CrawfordBE , Esko JD , Tor Y . 2007 . Guanidinylated neomycin delivers large , bioactive cargo into cells through a heparan sulfate - dependent pathway . J Biol Chem 282 : 13585 – 13591 . Endo K , Takino T , Miyamori H , Kinsen H , Yoshizaki T , Furukawa M , Sato H . 2003 . Cleavage of syndecan - 1 by membrane type matrix metalloproteinase - 1 stimulates cell migration . J Biol Chem 278 : 40764 – 40770 . Esko JD , Kimata K , Lindahl U . 2009 . Proteoglycans and Sul - fated Glycosaminoglycans . In Essentials of glycobiology ( ed . AVarki , et al . ) , pp . 229 – 248 . Cold Spring Harbor Laboratory Press , Cold Spring Harbor , NY . Esko JD , Linhardt RJ . 2009 . Proteins that bind sulfated glycosaminoglycans . in Essentials of glycobiology ( ed . AVarki , et al . ) , pp . 501 – 512 . Cold Spring Harbor Labo - ratory , Cold Spring Harbor , NY . Esko JD , Selleck SB . 2002 . Order out of chaos : Assembly of ligandbindingsitesinheparansulfate . AnnuRevBiochem 71 : 435 – 471 . Esko JD , Stewart TE , Taylor WH . 1985 . Animal cell mutants defective in glycosaminoglycan biosynthesis . Proc Natl Acad Sci 82 : 3197 – 3201 . Heparan Sulfate Proteoglycans Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 23 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from Eugster C , Panakova D , Mahmoud A , Eaton S . 2007 . Lipo - protein – heparan sulfate interactions in the Hh pathway . Dev Cell 13 : 57 – 71 . Fan G , Xiao L , Cheng L , Wang X , Sun B , Hu G . 2000 . Tar - geted disruption of NDST - 1 gene leads to pulmonary hypoplasia and neonatal respiratory distress in mice . FEBS Lett 467 : 7 – 11 . Feyzi E , Lustig F , Fager G , Spillmann D , Lindahl U , Salmi - virta M . 1997 . Characterization of heparin and heparan sulfate domains binding to the long splice variant of platelet - derived growth factor A chain . J Biol Chem 272 : 5518 – 5524 . Filmus J , Capurro M , Rast J . 2008 . Glypicans . Genome Biol 9 : 224 . FitzgeraldML , WangZH , Park PW , Murphy G , BernﬁeldM . 2000 . Shedding of syndecan - 1 and - 4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP - 3 - sensitive metalloproteinase . J Cell Biol 148 : 811 – 824 . Floer M , Gotte M , Wild MK , Heidemann J , Gassar ES , Domschke W , Kiesel L , Luegering A , Kucharzik T . 2010 . Enoxaparin improves the course of dextran sodium sulfate - induced colitis in syndecan - 1 - deﬁcient mice . Am J Pathol 176 : 146 – 157 . Forsberg E , Pejler G , Ringvall M , Lunderius C , Tomasini - Johansson B , Kusche - Gullberg M , Eriksson I , Ledin J , Hellman L , Kjelle´n L . 1999 . Abnormal mast cells in mice deﬁcient in a heparin - synthesizing enzyme . Nature 400 : 773 – 776 . Frankel AD , Pabo CO . 1988 . Cellular uptake of the tat pro - tein from human immunodeﬁciency virus . Cell 55 : 1189 – 1193 . FranssonLA˚ , Edgren G , HavsmarkB , SchmidtchenA . 1995 . Recycling of a glycosylphosphatidylinositol - anchored heparan sulphate proteoglycan ( glypican ) in skin ﬁbro - blasts . Glycobiology 5 : 407 – 415 . Fuki IV , Meyer ME , Williams KJ . 2000 . Transmembrane and cytoplasmic domains of syndecan mediate a multi - step endocytic pathway involving detergent - insoluble mem - brane rafts . Biochem J 351 : 607 – 612 . Fukai N , Eklund L , Marneros AG , Oh SP , Keene DR , Tamar - kin L , Niemela¨ M , Ilves M , Li E , Pihlajaniemi T , et al . 2002 . Lack of collagen XVIII / endostatin results in eye abnormalities . EMBO J 21 : 1535 – 1544 . Fukai N , Kenagy RD , Chen L , Gao L , Daum G , Clowes AW . 2009 . Syndecan - 1 : An inhibitor of arterial smooth muscle cell growth and intimal hyperplasia . Arterioscler Thromb Vasc Biol 29 : 1356 – 1362 . Fuki IV , Kuhn KM , Lomazov IR , Rothman VL , Tuszynski GP , Iozzo RV , Swenson TL , Fisher EA , Williams KJ . 1997 . Thesyndecanfamilyofproteoglycans . Novelrecep - tors mediating internalization of atherogenic lipopro - teins in vitro . J Clin Invest 100 : 1611 – 1622 . Fuster MM , Wang L , Castagnola J , Sikora L , Reddi K , Lee PHA , Radek K , Schuksz M , Bishop JR , Gallo RL , et al . 2007 . Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis . J Cell Biol 177 : 539 – 549 . Garner OB , Yamaguchi Y , Esko JD , Videm V . 2008 . Small changes in lymphocyte development and activation in mice through tissue - speciﬁc alteration of heparan sul - phate . Immunology 125 : 420 – 429 . Garner OB , Bush KT , Nigam KB , Yamaguchi Y , Xu D , Esko JD , Nigam SK . 2011 . Stage - dependent regulation of mammary ductal branching by heparan sulfate and HGF - cMet signaling . Dev Biol ( in press ) . Gautam M , Noakes PG , Moscoso L , Rupp F , Scheller RH , Merlie JP , Sanes JR . 1996 . Defective neuromuscular syn - aptogenesis in agrin - deﬁcient mutant mice . Cell 85 : 525 – 535 . GautamM , DeChiaraTM , GlassDJ , YancopoulosGD , Sanes JR . 1999 . Distinct phenotypes of mutant mice lacking agrin , MuSK , or rapsyn . Brain Res Dev Brain Res 114 : 171 – 178 . Geiger B , Yamada KM . 2011 . Molecular architecture and function of matrix adhesions . Cold Spring Harb Perspect Biol 3 : a005033 . Gingras J , Rassadi S , Cooper E , Ferns M . 2007 . Synaptic transmissionisimpairedatneuronalautonomicsynapsesinagrin - null mice . Dev Neurobiol 67 : 521 – 534 . Giro ´ s A , Morante J , Gil - Sanz C , Faire ´ n A , Costell M . 2007 . Perlecancontrolsneurogenesisinthedevelopingtelence - phalon . BMC Dev Biol 7 : 29 . GoldbergS , HarveySJ , CunninghamJ , TryggvasonK , Miner JH . 2009 . Glomerular ﬁltration is normal in the absence of both agrin and perlecan - heparan sulfate from the glo - merular basement membrane . Nephrol Dial Transplant 24 : 2044 – 2051 . Gopal S , Bober A , Whiteford JR , Multhaupt HA , Yoneda A , Couchman JR . 2010 . Heparan sulfate chain valency con - trols syndecan - 4 function in cell adhesion . J Biol Chem 285 : 14247 – 14258 . Gotte M , Kresse H . 2005 . Defective glycosaminoglycan sub - stitutionofdecorininapatientwithprogeroidsyndromeisadirectconsequenceoftwopointmutationsinthegalactosyltransferaseI ( b 4GalT - 7 ) gene . Biochem Genet 43 : 65 – 77 . GotteM , JoussenAM , KleinC , AndreP , WagnerDD , Hinkes MT , Kirchhof B , Adamis AP , Bernﬁeld M . 2002 . Role of syndecan - 1 in leukocyte - endothelial interactions in the ocular vasculature . Invest Ophthalmol Vis Sci 43 : 1135 – 1141 . Gotte M , Bernﬁeld M , Joussen AM . 2005 . Increased leuko - cyte – endothelial interactions in syndecan - 1 - deﬁcient mice involve heparan sulfate – dependent and – inde - pendent steps . Curr Eye Res 30 : 417 – 422 . GovindrajP , WestL , KoobTJ , NeameP , DoegeK , HassellJR . 2002 . Isolation and identiﬁcation of the major heparan sulfateproteoglycansinthedevelopingbovineribgrowthplate . J Biol Chem 277 : 19461 – 19469 . Greco V , Hannus M , Eaton S . 2001 . Argosomes : a potential vehicle for the spread of morphogens through epithelia . Cell 106 : 633 – 645 . Green M , Loewenstein PM . 1988 . Autonomous functional domains of chemically synthesized human immuno - deﬁciency virus tat trans - activator protein . Cell 55 : 1179 – 1188 . Grisaru S , Cano - Gauci D , Tee J , Filmus J , Rosenblum ND . 2001 . Glypican - 3 modulates BMP - and FGF - mediated effects during renal branching morphogenesis . Dev Biol 231 : 31 – 46 . Grobe K , Inatani M , Pallerla SR , Castagnola J , Yamaguchi Y , Esko JD . 2005 . Cerebral hypoplasia and craniofacial S . Sarrazin et al . 24 Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from defects in mice lacking heparan sulfate Ndst1 gene func - tion . Development 132 : 3777 – 3786 . Grujic M , Braga T , Lukinius A , Eloranta ML , Knight SD , Pejler G , Abrink M . 2005 . Serglycin - deﬁcient cytotoxic T lymphocytes display defective secretory granule mat - uration and granzyme B storage . J Biol Chem 280 : 33411 – 33418 . GrujicM , ChristensenJP , Sørensen MR , AbrinkM , PejlerG , Thomsen AR . 2008 . Delayed contraction of the CD8 þ T cell response toward lymphocytic choriomeningitis virus infection in mice lacking serglycin . J Immunol 181 : 1043 – 1051 . Grunewald FS , Prota AE , Giese A , Ballmer - Hofer K . 2010 . Structure - function analysis of VEGF receptor activation and the role of coreceptors in angiogenic signaling . Bio - chim Biophys Acta 1804 : 567 – 580 . GuimondS , MaccaranaM , Olwin BB , LindahlU , Rapraeger AC . 1993 . Activating and inhibitory heparin sequences for FGF - 2 ( basic FGF ) . Distinct requirements for FGF - 1 , FGF - 2 , and FGF - 4 . J Biol Chem 268 : 23906 – 23914 . Gutierrez J , Brandan E . 2010 . A novel mechanism of seques - tering ﬁbroblast growth factor 2byglypicanin lipid rafts , allowing skeletal muscle differentiation . Mol Cell Biol 30 : 1634 – 1649 . Habuchi H , Nagai N , Sugaya N , Atsumi F , Stevens RL , Kimata K . 2007 . Mice deﬁcient in heparan sulfate 6 - O - sulfotransferase - 1 exhibit defective heparan sulfate bio - synthesis , abnormal placentation , and late embryonic lethality . J Biol Chem 282 : 15578 – 15588 . Ha¨ckerU , LinXH , PerrimonN . 1997 . The Drosophilasugar - less gene modulates Wingless signaling and encodes an enzyme involved in polysaccharide biosynthesis . Devel - opment 124 : 3565 – 3573 . HajMohammadi S , Enjyoji K , Princivalle M , Christi P , Lech M , Beeler D , Rayburn H , Schwartz JJ , Barzegar S , De Agostini AI , et al . 2003 . Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis . J Clin Invest 111 : 989 – 999 . Hamano Y , Okude T , Shirai R , Sato I , Kimura R , Ogawa M , Ueda Y , Yokosuka O , KalluriR , UedaS . 2010 . Lackof col - lagen XVIII / endostatin exacerbates immune - mediated glomerulonephritis . J Am Soc Nephrol 21 : 1445 – 1455 . Han C , Yan D , Belenkaya TY , Lin X . 2005 . Drosophila glypi - cansDallyandDally - likeshapetheextracellularWingless morphogen gradient in the wing disc . Development 132 : 667 – 679 . Handel TM , Johnson Z , Crown SE , Lau EK , Proudfoot AE . 2005 . Regulation of protein function by glycosaminogly - cans – As exempliﬁed by chemokines . Annu Rev Biochem 74 : 385 – 410 . Harvey SJ , Jarad G , Cunningham J , Rops AL , van der Vlag J , BerdenJH , MoellerMJ , HolzmanLB , BurgessRW , Miner JH . 2007 . Disruptionof glomerular basementmembrane chargethroughpodocyte - speciﬁcmutationofagrindoes not alter glomerular permselectivity . Am J Pathol 171 : 139 – 152 . Hasegawa H , Wang F . 2008 . Visualizing mechanosensory endings of TrkC - expressing neurons in HS3ST - 2 - hPLAP mice . J Comp Neurol 511 : 543 – 556 . Hayashi Y , Kobayashi S , Nakato H . 2009 . Drosophila glypi - cans regulate the germline stem cell niche . J Cell Biol 187 : 473 – 480 . Hayashida K , Stahl PD , Park PW . 2008 . Syndecan - 1 ectodo - main shedding is regulated by the small GTPase Rab5 . J Biol Chem 283 : 35435 – 35444 . HayashidaA , Bartlett AH , Foster TJ , Park PW . 2009a . Staph - ylococcus aureus b - toxin induces lung injury through syndecan - 1 . Am J Pathol 174 : 509 – 518 . Hayashida K , Parks WC , Park PW . 2009b . Syndecan - 1 shed - ding facilitates the resolution of neutrophilic inﬂamma - tion by removing sequestered CXC chemokines . Blood 114 : 3033 – 3043 . Haynes A , Ruda F , Oliver J , Hamood AN , Griswold JA , Park PW , Rumbaugh KP . 2005 . Syndecan 1 shedding contrib - utes to Pseudomonas aeruginosa sepsis . Infect Immun 73 : 7914 – 7921 . Henningsson F , Hergeth S , Cortelius R , Abrink M , Pejler G . 2006 . A role for serglycin proteoglycan in granular reten - tionandprocessingofmastcellsecretorygranulecompo - nents . FEBS J 273 : 4901 – 4912 . Hienola A , Tumova S , Kulesskiy E , Rauvala H . 2006 . N - syndecan deﬁciency impairs neural migration in brain . J Cell Biol 174 : 569 – 580 . Hileman RE , Fromm JR , Weiler JM , Linhardt RJ . 1998 . Glycosaminoglycan – protein interactions : Deﬁnition of consensus sites in glycosaminoglycan binding proteins . BioEssays 20 : 156 – 167 . Hilgenberg LGW , Ho KD , Lee D , O’Dowd DK , Smith MA . 2002 . Agrin regulates neuronal responses to excitatory neurotransmitters in vitro and in vivo . Molec Cell Neuro - sci 19 : 97 – 110 . Holst CR , Bou - Reslan H , Gore BB , Wong K , Grant D , Cha - lasani S , Carano RA , Frantz GD , Tessier - Lavigne M , Bolon B , et al . 2007 . Secreted sulfatases Sulf1 and Sulf2 have overlapping yet essential roles in mouse neonatal survival . PLoS ONE 2 : e575 . Humphries DE , Wong GW , Friend DS , Gurish MF , Qiu WT , Huang CF , Sharpe AH , Stevens RL . 1999 . Heparin is essential for the storage of speciﬁc granule proteases in mast cells . Nature 400 : 769 – 772 . Hurskainen M , EklundL , Ha¨gg PO , Fruttiger M , Sormunen R , IlvesM , PihlajaniemiT . 2005 . Abnormalmaturationof the retinal vasculature in type XVIII collagen / endostatin deﬁcientmiceandchangesinretinalglialcellsduetolackofcollagentypesXVandXVIII . FASEB J 19 : 1564 – 1566 . Ilan N , Elkin M , Vlodavsky I . 2006 . Regulation , function and clinical signiﬁcance of heparanase in cancer metastasis and angiogenesis . Int J Biochem Cell Biol 38 : 2018 – 2039 . Inatani M , Irie F , Plump AS , Tessier - Lavigne M , Yamaguchi Y . 2003 . Mammalian brain morphogenesis and midline axon guidance require heparan sulfate . Science 302 : 1044 – 1046 . Iozzo RV , Zoeller JJ , Nystrom A . 2009 . Basement membrane proteoglycans : Modulators par excellence of cancer growth and angiogenesis . Mol Cells 27 : 503 – 513 . Ishiguro K , Kadomatsu K , Kojima T , Muramatsu H , Naka - mura E , Ito M , Nagasaka T , Kobayashi H , Kusugami K , Saito H , et al . 2000 . Syndecan - 4 deﬁciency impairs the Heparan Sulfate Proteoglycans Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 25 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from fetal vessels in the placental labyrinth . Dev Dyn 219 : 539 – 544 . Ishiguro K , Kadomatsu K , Kojima T , Muramatsu H , Iwase M , Yoshikai Y , Yanada M , Yamamoto K , Matsushita T , Nishimura M , et al . 2001 . Syndecan - 4 deﬁciency leads to high mortality of lipopolysaccharide - injected mice . J Biol Chem 276 : 47483 – 47488 . Ishiguro K , Kojima T , Muramatsu T . 2002 . Syndecan - 4 as a molecule involved in defense mechanisms . Glycoconj J 19 : 315 – 318 . Iwabuchi T , Goetinck PF . 2006 . Syndecan - 4 dependent FGF stimulation of mouse vibrissae growth . Mech Dev 123 : 831 – 841 . IzumikawaT , KanagawaN , WatamotoY , OkadaM , SaekiM , Sakano M , Sugahara K , Sugihara K , Asano M , Kitagawa H . 2010 . Impairment of embryonic cell division and glycosaminoglycan biosynthesis in glucuronyltransfer - ase - I - deﬁcient mice . J Biol Chem 285 : 12190 – 12196 . Izvolsky KI , Lu J , Martin G , Albrecht KH , Cardoso WV . 2008 . Systemic inactivation of Hs6st1 in mice is associ - ated with late postnatal mortality without major defects in organogenesis . Genesis 46 : 8 – 18 . Jackson SM , Nakato H , Sugiura M , Jannuzi A , Oakes R , Kaluza V , Golden C , Selleck SB . 1997 . dally , a Drosophila glypican , controlscellularresponsestotheTGF - b - related morphogen , Dpp . Development 124 : 4113 – 4120 . Jakobsson L , Kreuger J , Holmborn K , Lundin L , Eriksson I , Kjellen L , Claesson - Welsh L . 2006 . Heparan sulfate in trans potentiates VEGFR - mediated angiogenesis . Dev Cell 10 : 625 – 634 . Jen YH , Musacchio M , Lander AD . 2009 . Glypican - 1 con - trols brain size through regulation of ﬁbroblast growth factor signaling in early neurogenesis . Neural Dev 4 : 33 . Jiang D , Liang J , Campanella GS , Guo R , Yu S , Xie T , Liu N , Jung Y , Homer R , Meltzer EB , et al . 2010 . Inhibition of pulmonary ﬁbrosis in mice by CXCL10 requires glycosa - minoglycan binding and syndecan - 4 . J Clin Invest 120 : 2049 – 2057 . JohnsonCE , CrawfordBE , StavridisM , TenDamG , WatAL , RushtonG , WardCM , WilsonV , vanKuppeveltTH , Esko JD , et al . 2007 . Essential alterations of heparan sulfate during the differentiation of embryonic stem cells to Sox1 - enhanced green ﬂuorescent protein - expressing neural progenitor cells . Stem Cells 25 : 1913 – 1923 . JonesKB , PiomboV , SearbyC , KurrigerG , YangB , Grabellus F , Roughley PJ , Morcuende JA , Buckwalter JA , Capecchi MR , et al . 2010 . A mouse model of osteochondromagen - esis from clonal inactivation of Ext1 in chondrocytes . Proc Natl Acad Sci 107 : 2054 – 2059 . Kaksonen M , Pavlov I , Vo˜ikar V , Lauri SE , Hienola A , Riekki R , Lakso M , Taira T , Rauvala H . 2002 . Syndecan - 3 - deﬁcient mice exhibit enhanced LTP and impaired hippocampus - dependent memory . Molec Cell Neurosci 21 : 158 – 172 . Kamimura K , Koyama T , Habuchi H , Ueda R , Masu M , Kimata K , Nakato H . 2006 . Speciﬁc and ﬂexible roles of heparan sulfate modiﬁcations in Drosophila FGF signal - ing . J Cell Biol 174 : 773 – 778 . KanwarYS , LinkerA , FarquharMG . 1980 . Increasedperme - ability of the glomerular basement membrane to ferritin after removalof glycosaminoglycans ( heparan sulfate ) by enzyme digestion . J Cell Biol 86 : 688 – 693 . Kato M , Wang H , Bernﬁeld M , Gallagher JT , Turnbull JE . 1994 . Cellsurfacesyndecan - 1ondistinctcelltypesdiffers in ﬁne structure and ligand binding of its heparan sulfate chains . J Biol Chem 269 : 18881 – 18890 . KatoM , WangH , KainulainenV , FitzgeraldML , LedbetterS , Ornitz DM , Bernﬁeld M . 1998 . Physiological degrada - tion converts the soluble syndecan - 1 ectodomain from an inhibitor to a potent activator of FGF - 2 . Nat Med 4 : 691 – 697 . Kelly T , Suva LJ , Nicks KM , MacLeod V , Sanderson RD . 2010 . Tumor - derived syndecan - 1 mediates distal cross - talk with bone that enhances osteoclastogenesis . J Bone Miner Res 25 : 1295 – 1304 . KirkpatrickCA , DimitroffBD , RawsonJM , SelleckSB . 2004 . Spatial regulation of Wingless morphogen distribution and signaling by Dally - like protein . Dev Cell 7 : 513 – 523 . Kirkpatrick CA , Knox SM , Staatz WD , Fox B , Lercher DM , Selleck SB . 2006 . The function of a Drosophila glypican does not depend entirely on heparan sulfate modiﬁca - tion . Dev Biol 300 : 570 – 582 . Koenig A , Norgard - Sumnicht K , Linhardt R , Varki A . 1998 . Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins . Implications for the use of unfractionated and low molecular weight hep - arins as therapeutic agents . J Clin Invest 101 : 877 – 889 . Kon S , Ikesue M , Kimura C , Aoki M , Nakayama Y , Saito Y , Kurotaki D , Diao H , Matsui Y , Segawa T , et al . 2008 . Syndecan - 4 protects against osteopontin - mediated acute hepatic injury by masking functional domains of osteo - pontin . J Exp Med 205 : 25 – 33 . KramerKL , Yost HJ . 2002 . Ectodermalsyndecan - 2mediates left – right axis formation in migrating mesoderm as a cell - nonautonomous Vg1 cofactor . Dev Cell 2 : 115 – 124 . KraushaarDC , Yamaguchi Y , Wang L . 2010 . Heparan sulfate is required for embryonic stem cells to exit from self - renewal . J Biol Chem 285 : 5907 – 5916 . Kreuger J , Salmivirta M , Sturiale L , Gime´nez - Gallego G , Lindahl U . 2001 . Sequence analysis of heparan sulfate epitopes with graded afﬁnities for ﬁbroblast growth fac - tors 1 and 2 . J Biol Chem 276 : 30744 – 30752 . Kreuger J , Perez L , Giraldez AJ , Cohen SM . 2004 . Opposing activities of Dally - like glypican at high and low levels of Wingless morphogen activity . Dev Cell 7 : 503 – 512 . KsiazekI , BurkhardtC , LinS , SeddikR , MajM , BezakovaG , JuckerM , ArberS , CaroniP , SanesJR , etal . 2007 . Synapse loss in cortex of agrin - deﬁcient mice after genetic rescue of perinatal death . J Neurosci 27 : 7183 – 7195 . Lamanna WC , Baldwin RJ , Padva M , Kalus I , Ten Dam G , van Kuppevelt TH , Gallagher JT , von Figura K , Dierks T , Merry CL . 2006 . Heparan sulfate 6 - O - endosulfatases : discrete in vivo activities and functional co - operativity . Biochem J 400 : 63 – 73 . Lamanna WC , Kalus I , Padva M , Baldwin RJ , Merry CL , Dierks T . 2007 . The heparanome – The enigma of encod - ing and decoding heparan sulfate sulfation . J Biotechnol 129 : 290 – 307 . Lamanna WC , Frese MA , Balleininger M , Dierks T . 2008 . Sulf loss inﬂuences N - , 2 - O - , and 6 - O - sulfation of multiple heparan sulfate proteoglycans and modulates ﬁbroblast growth factor signaling . J Biol Chem 283 : 27724 – 27735 . S . Sarrazin et al . 26 Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from Lander AD . 2007 . Morpheus unbound : Reimagining the morphogen gradient . Cell 128 : 245 – 256 . Lander AD , Nie Q , Wan FY . 2002 . Do morphogen gradients arise by diffusion ? Dev Cell 2 : 785 – 796 . Lanner F , Lee KL , Sohl M , Holmborn K , Yang H , Wilbertz J , Poellinger L , Rossant J , Farnebo F . 2010 . Heparan sulfation - dependent ﬁbroblast growth factor signaling maintains embryonic stem cells primed for differentia - tion in a heterogeneous state . Stem Cells 28 : 191 – 200 . LaremoreTN , ZhangF , Dordick JS , Liu J , Linhardt RJ . 2009 . Recent progress and applications in glycosaminoglycan and heparin research . Curr Opin Chem Biol 13 : 633 – 640 . Lawrence R , Olson SK , Steele RE , Wang L , Warrior R , Cum - mings RD , Esko JD . 2008 . Evolutionary differences in glycosaminoglycan ﬁne structure detected by quantita - tive glycan reductive isotope labeling . J Biol Chem 283 : 33674 – 33684 . LeClair EE , Mui SR , Huang A , Topczewska JM , Topczewski J . 2009 . Craniofacial skeletal defects of adult zebraﬁsh Glypican 4 ( knypek ) mutants . Dev Dyn 238 : 2550 – 2563 . Li Q , Olsen BR . 2004 . Increased angiogenic response in aortic explants of collagen XVIII / endostatin - null mice . Am J Pathol 165 : 415 – 424 . Li JP , Vlodavsky I . 2009 . Heparin , heparan sulfate and heparanase in inﬂammatory reactions . Thromb Haemost 102 : 823 – 828 . LiQ , ParkPW , WilsonCL , ParksWC . 2002 . Matrilysinshed - ding of syndecan - 1 regulates chemokine mobilization and transepithelial efﬂux of neutrophils in acute lung injury . Cell 111 : 635 – 646 . Li JP , Gong F , Hagner - McWhirter A , Forsberg E , Abrink M , Kisilevsky R , Zhang X , Lindahl U . 2003 . Targeted disrup - tion of a murine glucuronyl C5 - epimerase gene results in heparan sulfate lacking L - iduronic acid and in neonatal lethality . J Biol Chem 278 : 28363 – 28366 . Li JP , Galvis ML , Gong F , Zhang X , Zcharia E , Metzger S , Vlodavsky I , Kisilevsky R , Lindahl U . 2005 . In vivo fragmentation of heparan sulfate by heparanase overex - pression renders mice resistant to amyloid protein A amyloidosis . Proc Natl Acad Sci 102 : 6473 – 6477 . Liem YS , Bode L , Freeze HH , Leebeek FW , Zandbergen AA , Paul Wilson J . 2008 . Using heparin therapy to reverse protein - losing enteropathy in a patient with CDG - Ib . Nat Clin Pract Gastroenterol Hepatol 5 : 220 – 224 . Lin XH , Buff EM , Perrimon N , Michelson AM . 1999 . Hep - aran sulfate proteoglycans are essential for FGF receptor signaling during Drosophila embryonic development . Development 126 : 3715 – 3723 . Lin X , Wei G , Shi ZZ , Dryer L , Esko JD , Wells DE , Matzuk MM . 2000 . Disruption of gastrulation and heparan sul - fate biosynthesis in EXT1 - deﬁcient mice . Dev Biol 224 : 299 – 311 . Lindahl U , Li JP . 2009 . Interactions between heparan sulfate and proteins—Design and functional implications . Int Rev Cell Mol Biol 276 : 105 – 159 . Lindahl B , Lindahl U . 1997 . Amyloid - speciﬁc heparan sulfate from human liver and spleen . J Biol Chem 272 : 26091 – 26094 . Lindahl U , Backstrom G , Thunberg L , Leder IG . 1980 . Evi - dence for a 3 - O - sulfated D - glucosamine residue in the antithrombin - binding sequence of heparin . Proc Natl Acad Sci 77 : 6551 – 6555 . Longley RL , Woods A , Fleetwood A , Cowling GJ , Gallagher JT , Couchman JR . 1999 . Control of morphology , cyto - skeleton and migration by syndecan - 4 . J Cell Sci 112 : 3421 – 3431 . Lortat - Jacob H . 2009 . The molecular basis and functional implications of chemokine interactions with heparan sulphate . Curr Opin Struct Biol 19 : 543 – 548 . Lortat - Jacob H , Turnbull JE , Grimaud JA . 1995 . Molecular organization of the interferon g - binding domain in heparan sulphate . Biochem J 310 : 497 – 505 . Lortat - Jacob H , Grosdidier A , Imberty A . 2002 . Structural diversity of heparan sulfate binding domains in chemo - kines . Proc Natl Acad Sci 99 : 1229 – 1234 . Lum DH , Tan J , Rosen SD , Werb Z . 2007 . Gene trap disrup - tion of the mouse heparan sulfate 6 - O - endosulfatase gene , Sulf2 . Mol Cell Biol 27 : 678 – 688 . Lyon M , Deakin JA , Mizuno K , Nakamura T , Gallagher JT . 1994 . Interaction of hepatocyte growth factor with heparan sulfate . Elucidation of the major heparan sulfate structural determinants . J Biol Chem 269 : 11216 – 11223 . MacArthurJM , BishopJR , WangL , StanfordKI , Bensadoun A , Witztum JL , Esko JD . 2007 . Liver heparan sulfate proteoglycans mediate clearance of triglyceride - rich lipoproteins independently of LDL receptor family members . J Clin Invest 117 : 153 – 164 . Maccarana M , Lindahl U . 1993 . Mode of interaction between platelet factor 4 and heparin . Glycobiology 3 : 271 – 277 . Maccarana M , Casu B , Lindahl U . 1993 . Minimal sequence in heparin / heparan sulfate required for binding of basic ﬁbroblast growth factor . J Biol Chem 268 : 23898 – 23905 . Makino H , Ikeda S , Haramoto T , Ota Z . 1992 . Heparan sulfate proteoglycans are lost in patients with diabetic nephropathy . Nephron 61 : 415 – 421 . Manon - JensenT , ItohY , CouchmanJR . 2010 . Proteoglycans in health and disease : The multiple roles of syndecan shedding . Febs J 277 : 3876 – 3889 . Marneros AG , Olsen BR . 2001 . The role of collagen - derived proteolytic fragments in angiogenesis . Matrix Biol 20 : 337 – 345 . Marneros AG , Olsen BR . 2003 . Age - dependent iris abnor - malities in collagen XVIII / endostatin deﬁcient mice with similarities to human pigment dispersion syn - drome . Investig Ophthal Visual Sci 44 : 2367 – 2372 . Marneros AG , She H , Zambarakji H , Hashizume H , Con - nolly EJ , Kim I , Gragoudas ES , Miller JW , Olsen BR . 2007 . Endogenous endostatin inhibits choroidal neovas - cularization . FASEB J 21 : 3809 – 3818 . Marois E , Mahmoud A , Eaton S . 2006 . The endocytic path - way and formation of the Wingless morphogen gradient . Development 133 : 307 – 317 . Masouleh BK , Ten Dam GB , Wild MK , Seelige R , van der Vlag J , Rops AL , Echtermeyer FG , Vestweber D , van Kup - pevelt TH , Kiesel L , et al . 2009 . Role of the heparan sul - fate proteoglycan syndecan - 1 ( CD138 ) in delayed - type hypersensitivity . J Immunol 182 : 4985 – 4993 . Matsumoto K , Irie F , Mackem S , Yamaguchi Y . 2010 . A mouse model of chondrocyte - speciﬁc somatic mutation reveals a role for Ext1 loss of heterozygosity in multiple Heparan Sulfate Proteoglycans Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 27 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from hereditary exostoses . Proc Natl Acad Sci 107 : 10932 – 10937 . Matsumoto - Miyai K , Sokolowska E , Zurlinden A , Gee CE , Luscher D , Hettwer S , Wolfel J , Ladner AP , Ster J , Gerber U , et al . 2009 . Coincident pre - and postsynaptic acti - vation induces dendritic ﬁlopodia via neurotrypsin - dependent agrin cleavage . Cell 136 : 1161 – 1171 . Matthews HK , Marchant L , Carmona - Fontaine C , Kur - iyama S , Larrain J , Holt MR , Parsons M , Mayor R . 2008 . Directional migration of neural crest cells in vivo is regulated by Syndecan - 4 / Rac1 and non - canonical Wnt signaling / RhoA . Development 135 : 1771 – 1780 . McDermott SP , Ranheim EA , Leatherberry VS , Khwaja SS , Klos KS , Alexander CM . 2007 . Juvenile syndecan - 1 null mice are protected from carcinogen - induced tumor development . Oncogene 26 : 1407 – 1416 . McKeehanWL , WuXC , KanM . 1999 . Requirementforanti - coagulant heparan sulfate in the ﬁbroblast growth factor receptor complex . J Biol Chem 274 : 21511 – 21514 . McLaughlin D , Karlsson F , Tian N , Pratt T , Bullock SL , Wil - son VA , Price DJ , Mason JO . 2003 . Speciﬁc modiﬁcation of heparan sulphate is required for normal cerebral cor - tical development . Mech Dev 120 : 1481 – 1488 . McQuade KJ , Beauvais DM , Burbach BJ , Rapraeger AC . 2006 . Syndecan - 1 regulates a v b 5 integrin activity in B82L ﬁbroblasts . J Cell Sci 119 : 2445 – 2456 . MerryCLR , BullockSL , SwanDC , BackenAC , LyonM , Bed - dington RSP , Wilson VA , Gallagher JT . 2001 . The molec - ular phenotype of heparan sulfate in the Hs2st 2 / 2 mutant mouse . J Biol Chem 276 : 35429 – 35434 . Miner JH . 1999 . Renal basement membrane components . Kidney Int 56 : 2016 – 2024 . Mitsi M , Hong Z , Costello CE , Nugent MA . 2006 . Heparin - mediated conformational changes in ﬁbronectin expose vascular endothelial growth factor binding sites . Bio - chemistry 45 : 10319 – 10328 . Mitsi M , Forsten - Williams K , Gopalakrishnan M , Nugent MA . 2008 . A catalytic role of heparin within the extracel - lular matrix . J Biol Chem 283 : 34796 – 34807 . Morgan MR , Humphries MJ , Bass MD . 2007 . Synergistic control of cell adhesion by integrins and syndecans . Nat Rev Mol Cell Biol 8 : 957 – 969 . Morita H , Yoshimura A , Inui K , Ideura T , Watanabe H , WangL , SoininenR , TryggvasonK . 2005 . Heparansulfate of perlecan is involved in glomerular ﬁltration . J Am Soc Nephrol 16 : 1703 – 1710 . Moulton KS , Olsen BR , Sonn S , Fukai N , Zurakowski D , Zeng X . 2004 . Loss of collagen XVIIIenhances neovascu - larization and vascular permeability in atherosclerosis . Circulation 110 : 1330 – 1336 . Mulloy B , Linhardt RJ . 2001 . Orderout of complexity – Pro - tein structures that interact with heparin . Curr Opin Struct Biol 11 : 623 – 628 . Munoz R , Moreno M , Oliva C , Orbenes C , Larrain J . 2006 . Syndecan - 4 regulates non - canonical Wnt signalling and is essential for convergent and extension movements in Xenopus embryos . Nat Cell Biol 8 : 492 – 500 . Murakami M , Horowitz A , Tang S , Ware JA , Simons M . 2002 . Protein kinase C ( PKC ) d regulates PKC a activity in a syndecan - 4 - dependent manner . J Biol Chem 277 : 20367 – 20371 . Murch SH , MacDonald TT , Walker - Smith JA , Levin M , LionettiP , KleinNJ . 1993 . Disruptionof sulphatedglyco - saminoglycans in intestinal inﬂammation . Lancet 341 : 711 – 714 . Murch SH , Winyard PJD , Koletzko S , Wehner B , Cheema HA , Risdon RA , Phillips AD , Meadows N , Klein NJ , Walker - Smith JA . 1996 . Congenital enterocyte heparan sulphate deﬁciency with massive albumin loss , secretory diarrhoea , and malnutrition . Lancet 347 : 1299 – 1301 . Nakato H , Futch TA , Selleck SB . 1995 . The division abnor - mally delayed ( dally ) gene : A putative integral membrane proteoglycan required for cell division patterning during postembryonic development of the nervous system in Drosophila . Development 121 : 3687 – 3702 . Ng A , Wong M , Viviano B , Erlich JM , Alba G , Pﬂederer C , Jay PY , Saunders S . 2009 . Loss of glypican - 3 function causes growth factor - dependent defects in cardiac and coronary vascular development . Dev Biol 335 : 208 – 215 . Nicole S . 2000 . Perlecan , the major proteoglycan of base - ment membranes , is altered in patients with Schwartz – Jampel syndrome ( chondrodystrophic myotonia ) . Nature Genetics 26 : 480 – 483 . Niemann CU , Abrink M , Pejler G , Fischer RL , Christensen EI , Knight SD , Borregaard N . 2007 . Neutrophil elastase depends on serglycin proteoglycan for localization in granules . Blood 109 : 4478 – 4486 . Noguer O , Villena J , Lorita J , Vilaro´ S , Reina M . 2009 . Syndecan - 2 downregulation impairs angiogenesis in human microvascular endothelial cells . Exp Cell Res 315 : 795 – 808 . Norgard - Sumnicht KE , Varki A . 1995 . Endothelial heparan sulfate proteoglycans that bind to L - selectin have glucos - amine residues with unsubstituted amino groups . J Biol Chem 270 : 12012 – 12024 . Nurcombe V , Cool SM . 2007 . Heparan sulfate control of proliferation and differentiation in the stem cell niche . Crit Rev Eukaryot Gene Expr 17 : 159 – 171 . OhES , CouchmanJR . 2004 . Syndecans - 2and - 4 ; closecous - ins , but not identical twins . Mol Cells 17 : 181 – 187 . Oh ES , Couchman JR , Woods A . 1997a . Serine phosphory - lation of syndecan - 2 proteoglycan cytoplasmic domain . Arch Biochem Biophys 344 : 67 – 74 . Oh ES , Woods A , Couchman JR . 1997b . Multimerization of the cytoplasmic domain of syndecan - 4 is required for its ability to activate protein kinase C . J Biol Chem 272 : 11805 – 11811 . Oh ES , WoodsA , CouchmanJR . 1997c . Syndecan - 4 proteo - glycan regulates the distribution and activity of protein kinase C . J Biol Chem 272 : 8133 – 8136 . Okina E , Manon - Jensen T , Whiteford JR , Couchman JR . 2009 . Syndecan proteoglycan contributionsto cytoskele - tal organization and contractility . Scand J Med Sci Sports 19 : 479 – 489 . Ono K , Hattori H , Takeshita S , Kurita A , Ishihara M . 1999 . Structural features in heparin that interact with VEGF 165 and modulate its biological activity . Glycobiology 9 : 705 – 711 . Ori A , Wilkinson MC , Fernig DG . 2008 . The heparanome and regulation of cell function : Structures , functions and challenges . Front Biosci 13 : 4309 – 4338 . S . Sarrazin et al . 28 Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from Otsuki S , Hanson SR , Miyaki S , Grogan SP , Kinoshita M , Asahara H , Wong CH , Lotz MK . 2010 . Extracellular sul - fatases support cartilage homeostasis by regulating BMP and FGF signaling pathways . Proc Natl Acad Sci 107 : 10202 – 10207 . Pallerla SR , Lawrence R , Lewejohann L , Pan Y , Fischer T , Schlomann U , Zhang X , Esko JD , Grobe K . 2008 . Altered heparan sulfate structure in mice with deleted NDST3 gene function . J Biol Chem 283 : 16885 – 16894 . PanY , WoodburyA , Esko JD , GrobeK , ZhangX . 2006 . Hep - aran sulfate biosynthetic gene Ndst1 is required for FGF signaling in early lens development . Development 133 : 4933 – 4944 . PanY , CarbeC , PowersA , ZhangEE , EskoJD , GrobeK , Feng GS , Zhang X . 2008 . Bud speciﬁc N - sulfation of heparan sulfate regulates Shp2 - dependent FGF signaling during lacrimal gland induction . Development 135 : 301 – 310 . ParkPW , PierGB , PrestonMJ , GoldbergerO , FitzgeraldML , Bernﬁeld M . 2000a . Syndecan - 1 shedding is enhanced by LasA , a secreted virulence factor of Pseudomonas aerugi - nosa . J Biol Chem 275 : 3057 – 3064 . Park PW , Reizes O , Bernﬁeld M . 2000b . Cell surfaceheparan sulfate proteoglycans : Selective regulators of ligand - receptor encounters . J Biol Chem 275 : 29923 – 29926 . Park PW , Pier GB , Hinkes MT , Bernﬁeld M . 2001 . Exploita - tion of syndecan - 1 shedding by Pseudomonas aeruginosa enhances virulence . Nature 411 : 98 – 102 . Parthasarathy N , Goldberg IJ , Sivaram P , Mulloy B , Flory DM , Wagner WD . 1994 . Oligosaccharide sequences of endothelial cell surface heparan sulfate proteoglycan with afﬁnity for lipoprotein lipase . J Biol Chem 269 : 22391 – 22396 . PartovianC , JuR , ZhuangZW , MartinKA , SimonsM . 2008 . Syndecan - 4 regulates subcellular localization of mTOR complex2andAktactivationinaPKC a - dependentman - ner in endothelial cells . Molec Cell 32 : 140 – 149 . Patterson AM , Gardner L , Shaw J , David G , Loreau E , Agui - lar L , Ashton BA , Middleton J . 2005 . Induction of a CXCL8 binding site on endothelial syndecan - 3 in rheu - matoid synovium . Arthritis Rheum 52 : 2331 – 2342 . Pilia G , Hughes - Benzie RM , MacKenzie A , Baybayan P , Chen EY , Huber R , Neri G , Cao A , Forabosco A , Schles - singer D . 1996 . Mutations in GPC3 , a glypican gene , cause the Simpson – Golabi – Behmel overgrowth syn - drome [ see comments ] . Nat Genet 12 : 241 – 247 . Poon GM , Gariepy J . 2007 . Cell - surface proteoglycans as molecular portals forcationicpeptide and polymerentry into cells . Biochem Soc Trans 35 : 788 – 793 . Pratt T , Conway CD , Tian NM , Price DJ , Mason JO . 2006 . Heparan sulphation patterns generated by speciﬁc hep - aran sulfotransferase enzymes direct distinct aspects of retinal axon guidance at the optic chiasm . J Neurosci 26 : 6911 – 6923 . Proudfoot AEI , Handel TM , Johnson Z , Lau EK , LiWang P , Clark - Lewis I , Borlat F , Wells TNC , Kosco - Vilbois MH . 2003 . Glycosaminoglycan binding and oligomerization areessentialfortheinvivoactivityofcertainchemokines . Proc Natl Acad Sci 100 : 1885 – 1890 . Pruessmeyer J , Martin C , Hess FM , Schwarz N , Schmidt S , Kogel T , Hoettecke N , Schmidt B , Sechi A , Uhlig S , et al . 2010 . A disintegrin and metalloproteinase 17 ( ADAM17 ) mediates inﬂammation - induced shedding of syndecan - 1 and - 4 by lung epithelial cells . J Biol Chem 285 : 555 – 564 . Qu X , CarbeC , TaoC , PowersA , LawrenceR . vanKuppevelt TH , Cardoso WV , GrobeK , Esko JD , ZhangX . 2011 . Lac - rimal gland development and Fgf10 - Fgfr2b signaling are controlledby2 - 0 - and6 - 0 - sulfatedheparansulfate . JBioi Chem 286 : 14435 – 14444 . Raats CJI , Van den Born J , Berden JHM . 2000 . Glomerular heparan sulfate alterations : Mechanisms and relevance for proteinuria . Kidney Int 57 : 385 – 400 . Rapraeger AC , Krufka A , Olwin BB . 1991 . Requirement of heparan sulfate for bFGF - mediated ﬁbroblast growth and myoblast differentiation . Science 252 : 1705 – 1708 . RatzkaA , KalusI , MoserM , DierksT , MundlosS , Vortkamp A . 2008 . Redundant function of the heparan sulfate 6 - O - endosulfatases Sulf1and Sulf2 during skeletaldevel - opment . Dev Dyn 237 : 339 – 353 . Reizes O , Benoit SC , Strader AD , Clegg DJ , Akunuru S , Seeley RJ . 2003 . Syndecan - 3 modulates food intake by interacting with the melanocortin / AgRP pathway . Ann NYAcad Sci 994 : 66 – 73 . RenY , KirkpatrickCA , RawsonJM , SunM , SelleckSB . 2009 . Cell type - speciﬁc requirements for heparan sulfate bio - synthesis at the Drosophila neuromuscular junction : Effects on synapse function , membrane trafﬁcking , and mitochondrial localization . J Neurosci 29 : 8539 – 8550 . Richardson GD , Fantauzzo KA , Bazzi H , Ma¨a¨tta¨ A , Jahoda CAB . 2009 . Dynamic expression of Syndecan - 1 during hair follicle morphogenesis . Gene Express Patterns 9 : 454 – 460 . RietveldA , NeutzS , SimonsK , EatonS . 1999 . Associationof sterol - and glycosylphosphatidylinositol - linked proteins with Drosophila raft lipid microdomains . J Biol Chem 274 : 12049 – 12054 . Ringvall M , Ledin J , Holmborn K , Van Kuppevelt T , Ellin F , Eriksson I , Olofsson AM , Kjelle´n L , Forsberg E . 2000 . Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N - deacetylase / N - sulfotransfer - ase - 1 . J Biol Chem 275 : 25926 – 25930 . Robinson CJ , Mulloy B , Gallagher JT , Stringer SE . 2006 . VEGF165 - binding sites within heparan sulfate encom - pass two highly sulfated domains and can be liberated by K5 lyase . J Biol Chem 281 : 1731 – 1740 . RodgersKD , SanAntonioJD , JacenkoO . 2008 . Heparansul - fate proteoglycans : A GAGgle of skeletal - hematopoietic regulators . Dev Dyn 237 : 2622 – 2642 . RogalskiTM , WilliamsBD , MullenGP , MoermanDG . 1993 . Productsof the unc - 52gene in Caenorhabditiselegans are homologous to the core protein of the mammalian base - ment membrane heparan sulfate proteoglycan . Genes 7 : 1471 – 1484 . Rops AL , Go¨tte M , Baselmans MH , van den Hoven MJ , Steenbergen EJ , Lensen JF , Wijnhoven TJ , Cevikbas F , van den Heuvel LP , van Kuppevelt TH , et al . 2007 . Syndecan - 1 deﬁciency aggravates anti - glomerular base - ment membrane nephritis . Kidney Int 72 : 1204 – 1215 . RossiM , MoritaH , SormunenR , AirenneS , KreiviM , Wang L , Fukai N , Olsen BR , Tryggvason K , Soininen R . 2003 . Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney . EMBO J 22 : 236 – 245 . Heparan Sulfate Proteoglycans Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 29 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from SadirR , ImbertyA , BaleuxF , Lortat - JacobH . 2004 . Heparan sulfate / heparin oligosaccharides protect stromal cell - derived factor - 1 ( SDF - 1 ) / CXCL12 against proteolysis induced by CD26 / dipeptidyl peptidase IV . J Biol Chem 279 : 43854 – 43860 . Sanderson RD , Yang Y . 2008 . Syndecan - 1 : A dynamic regulator of the myeloma microenvironment . Clin Exp Metastasis 25 : 149 – 159 . Saoncella S , Echtermeyer F , Denhez F , Nowlen JK , Mosher DF , Robinson SD , Hynes RO , Goetinck PF . 1999 . Syndecan - 4signalscooperativelywithintegrinsinaRho - dependent manner in the assembly of focal adhesions and actin stress ﬁbers . Proc Natl Acad Sci 96 : 2805 – 2810 . Sarraj MA , Escalona RM , Umbers A , Chua HK , Small C , Griswold M , Loveland K , Findlay JK , Stenvers KL . 2010 . Fetal testis dysgenesis and compromised Leydig cell function in Tgfbr3 ( betaglycan ) knockout mice . Biol Reprod 82 : 153 – 162 . Sarrazin S , Wilson B , Sly WS , Tor Y , Esko JD . 2010 . Guani - dinylated neomycin mediates heparan sulfate – depend - ent transport of active enzymes to lysosomes . Mol Ther 18 : 1268 – 1274 . Sasisekharan R , Raman R , Prabhakar V . 2006 . Glycomics approach to structure – function relationships of glycosa - minoglycans . Annu Rev Biomed Eng 8 : 181 – 231 . Sasse P , Malan D , Fleischmann M , Roell W , Gustafsson E , Bostani T , Fan Y , Kolbe T , Breitbach M , Addicks K , et al . 2008 . Perlecan is critical for heart stability . Cardiovasc Res 80 : 435 – 444 . Sato N , Meijer L , Skaltsounis L , Greengard P , Brivanlou AH . 2004 . Maintenanceofpluripotencyinhumanandmouse embryonicstemcellsthroughactivationofWntsignalingbyapharmacologicalGSK - 3 - speciﬁc inhibitor . Nat Med 10 : 55 – 63 . Schellings MWM , Vanhoutte D , van Almen GC , Swinnen M , Leenders JJG , Kubben N , van Leeuwen REW , Hofstra L , Heymans S , Pinto YM . 2010 . Syndecan - 1 ampliﬁes angiotensin II – induced cardiac ﬁbrosis . Hypertension 55 : 249 – 256 . Schwartz MA . 2010 . Integrins and extracellular matrix in mechanotransduction . Cold Spring Harb Perspect Biol 2 : a005066 . Seidler DG , Faiyaz - Ul - Haque M , Hansen U , Yip GW , Zaidi SH , Teebi AS , Kiesel L , Gotte M . 2006 . Defective glycosy - lation of decorin and biglycan , altered collagen structure , and abnormal phenotype of the skin ﬁbroblasts of an Ehlers – Danlos syndrome patient carrying the novel Arg270Cys substitution in galactosyltransferase I ( b 4GalT - 7 ) . J Mol Med 84 : 583 – 594 . Seppinen L , Sormunen R , Soini Y , Elamaa H , Heljasvaara R , Pihlajaniemi T . 2008 . Lack of collagen XVIII accelerates cutaneous wound healing , while overexpression of its endostatin domain leads to delayed healing . Matrix Biol 27 : 535 – 546 . Serpinskaya AS , Feng G , Sanes JR , Craig AM . 1999 . Synapse formation by hippocampal neurons from agrin - deﬁcient mice . Dev Biol 205 : 65 – 78 . Sertie AL , Sossi V , Camargo AA , Zatz M , Brahe C , Passos - Bueno MR . 2000 . Collagen XVIII , containing an endog - enous inhibitor of angiogenesis and tumor growth , plays a critical role in the maintenance of retinal structure and in neural tube closure ( Knobloch syndrome ) . Hum Mol Genet 9 : 2051 – 2058 . Shukla D , Liu J , Blaiklock P , Shworak NW , Bai XM , Esko JD , CohenGH , EisenbergRJ , RosenbergRD , SpearPG . 1999 . A novel role for 3 - O - sulfated heparan sulfate in herpes simplex virus 1 entry . Cell 99 : 13 – 22 . Shworak NW , Kojima T , Rosenberg RD . 1993 . Isolation and characterization of ryudocan and syndecan heparan sul - fate proteoglycans , core proteins , and cDNAs from a rat endothelial cell line . Haemostasis 23 : 161 – 176 . ShworakNW , HajMohammadiS , DeAgostiniAI , Rosenberg RD . 2002 . Mice deﬁcient in heparan sulfate 3 - O - sulfotransferase - 1 : Normal hemostasis with unexpected perinatal phenotypes . Glycoconj J 19 : 355 – 361 . Smith EM , Mitsi M , Nugent MA , Symes K . 2009 . PDGF - A interactions withﬁbronectinrevealacriticalrole forhep - aran sulfate in directed cell migration during Xenopus gastrulation . Proc Natl Acad Sci 106 : 21683 – 21688 . Smits NC , Kurup S , Rops AL , Ten Dam GB , Massuger LF , Hafmans T , Turnbull JE , Spillmann D , Li JP , Kennel SJ , et al . 2010 . The heparan sulfate motif ( GlcNS6S - IdoA2S ) 3 , common in heparin , has a strict topography and is involved in cell behavior and disease . J Biol Chem 285 : 41143 – 41151 . Soker S , Goldstaub D , Svahn CM , Vlodavsky I , Levi B - Z , Neufeld G . 1994 . Variations in the size and sulfation of heparin modulate the effect of heparin on the binding of VEGF 165 to its receptors . Biochem Biophys Res Com - mun 203 : 1339 – 1347 . Song HH , Shi W , Xiang Y - Y , Filmus J . 2005 . The loss of glypican - 3 induces alterations in Wnt signaling . J Biol Chem 280 : 2116 – 2125 . Spillmann D , Lookene A , Olivecrona G . 2006 . Isolation and characterization of low sulfated heparan sulfate sequen - ces with afﬁnity for lipoprotein lipase . J Biol Chem 281 : 23405 – 23413 . StanfordKI , BishopJR , FoleyEM , GonzalesJC , NiesmanIR , Witztum J . L , Esko JD . 2009 . Syndecan - 1 is the primary heparansulfateproteoglycanmediatinghepaticclearanceoftriglyceride - richlipoproteinsinmice . JClinInvest 119 : 3236 – 3245 . Stanford KI , Wang L , Castagnola J , Song D , Bishop JR , Brown JR , Lawrence R , Bai X , Habuchi H , Tanaka M , et al . 2010 . Heparan sulfate 2 - O - sulfotransferase is required for triglyceride - rich lipoprotein clearance . J Biol Chem 285 : 286 – 294 . Stenvers KL , Tursky ML , Harder KW , Kountouri N , Amatayakul - Chantler S , Grail D , Small C , Weinberg RA , Sizeland AM , Zhu HJ . 2003 . Heart and liver defects and reduced transforming growth factor b 2 sensitivity in transforming growth factor b type III receptor – deﬁ - cient embryos . Mol Cell Biol 23 : 4371 – 4385 . Stepp MA , Gibson HE , Gala PH , Iglesia DDS , Pajoohesh - Ganji A , Pal - Ghosh S , Brown M , Aquino C , Schwartz AM , Goldberger O , et al . 2002 . Defects in keratinocyte activation during wound healing in the syndecan - 1 - deﬁcient mouse . J Cell Sci 115 : 4517 – 4531 . Stevenson JL , Varki A , Borsig L . 2007 . Heparin attenuates metastasis mainly due to inhibition of P - and L - selectin , but non - anticoagulant heparins can have additional effects . Thromb Res 120 : S107 – S111 . S . Sarrazin et al . 30 Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from Stickens D , Zak BM , Rougier N , Esko JD , Werb Z . 2005 . Mice deﬁcient in Ext2 lack heparan sulfate and develop exostoses . Development 132 : 5055 – 5068 . StraderAD , ReizesO , WoodsSC , BenoitSC , SeeleyRJ . 2004 . Mice lacking the syndecan - 3 gene are resistant to diet - induced obesity . J Clin Invest 114 : 1354 – 1360 . Stringer SE , Gallagher JT . 1997 . Speciﬁc binding of the che - mokine platelet factor 4 to heparan sulfate . J Biol Chem 272 : 20508 – 20514 . Stringer SE , Forster MJ , Mulloy B , Bishop CR , Graham GJ , Gallagher JT . 2002 . Characterization of the binding site onheparansulfateformacrophageinﬂammatoryprotein1 a . Blood 100 : 1543 – 1550 . Stringer SE , Nelson MS , Gupta P . 2003 . Identiﬁcation of an MIP - 1 a - binding heparan sulfate oligosaccharide that supports long - term in vitro maintenance of human LTC - ICs . Blood 101 : 2243 – 2245 . Sugahara K , Kitagawa H . 2002 . Heparin and heparan sulfate biosynthesis . IUBMB Life 54 : 163 – 175 . SugayaN , HabuchiH , NagaiN , Ashikari - HadaS , KimataK . 2008 . 6 - O - sulfation of heparan sulfate differentially regulates various ﬁbroblast growth factor - dependent sig - nalings in culture . J Biol Chem 283 : 10366 – 10376 . SymesK , SmithEM , MitsiM , NugentMA . 2010 . Sweetcues : How heparan sulfate modiﬁcation of ﬁbronectin enables growth factor guided migration of embryonic cells . Cell Adh Migr 4 : 507 – 510 . TakahashiI , NoguchiN , Nata K , Yamada S , Kaneiwa T , Miz - umoto S , Ikeda T , Sugihara K , Asano M , Yoshikawa T , et al . 2009 . Important role of heparan sulfate in postnatal islet growth and insulin secretion . Biochem Biophys Res Commun 383 : 113 – 118 . Takeo S , Akiyama T , Firkus C , Aigaki T , Nakato H . 2005 . Expression of a secreted form of Dally , a Drosophila gly - pican , induces overgrowth phenotype by affecting action range of Hedgehog . Dev Biol 284 : 204 – 218 . Tamsma JT , van den Born J , Bruijn JA , Assmann KJ , Ween - ing JJ , Berden JH , Wieslander J , Schrama E , Hermans J , Veerkamp JH , et al . 1994 . Expression of glomerular extracellular matrix components in human diabetic nephropathy : Decrease of heparan sulphate in the glo - merularbasementmembrane . Diabetologia 37 : 313 – 320 . Taylor DR , Whitehouse IJ , Hooper NM . 2009 . Glypican - 1 mediates both prion protein lipid raft association and disease isoform formation . PLoS Pathog 5 : e1000666 . Telci D , Wang Z , Li X , Verderio EAM , Humphries MJ , Bac - carini M , Basaga H , Grifﬁn M . 2008 . Fibronectin - tissue transglutaminase matrix rescues RGD - impaired cell adhesion through syndecan - 4 and b 1 integrin co - signal - ing . J Biol Chem 283 : 20937 – 20947 . The I , Bellaiche Y , Perrimon N . 1999 . Hedgehog movement is regulated through tout velu - dependent synthesis of a heparan sulfate proteoglycan . Mol Cell 4 : 633 – 639 . Thompson WR , Modla S , Grindel BJ , Czymmek KJ , Kirn - Safran CB , Wang L , Duncan RL , Farach - Carson MC . 2011 . Perlecan / Hspg2 deﬁciency alters the pericellular space of the lacuno - canalicular system surrounding osteocytic processes in cortical bone . J Bone Mineral Res 26 : 618 – 629 . Tkachenko E , Lutgens E , Stan RV , Simons M . 2004 . Fibro - blast growth factor 2 endocytosis in endothelial cells proceed via syndecan - 4 - dependent activation of Rac1 and a Cdc42 - dependent macropinocytic pathway . J Cell Sci 117 : 3189 – 3199 . TkachenkoE , RhodesJM , SimonsM . 2005 . Syndecans : New kids on the signaling block . Circ Res 96 : 488 – 500 . Topczewski J , Sepich DS , Myers DC , Walker C , Armores A , Lele Z , Hammerschmidt M , Postlethwait J , Solnica - Kre - zel L . 2001 . The zebraﬁsh glypican knypek controls cell polarity during gastrulation movements of convergent extension . Dev Cell 1 : 251 – 264 . Tran - Lundmark K , Tran PK , Paulsson - Berne G , Friden V , Soininen R , Tryggvason K , Wight TN , Kinsella MG , BorenJ , etal . 2008 . Heparansulfateinperlecanpromotes mouse atherosclerosis : Roles in lipid permeability , lipid retention , and smooth muscle cell proliferation . Circ Res 103 : 43 – 52 . Tsuda M , Kamimura K , Nakato H , Archer M , Staatz W , Fox B , Humphrey M , Olson S , Futch T , Kaluza V , et al . 1999 . The cell - surface proteoglycan Dally regulates Wingless signalling in Drosophila . Nature 400 : 276 – 280 . Tveit H , Dick G , Skibeli V , Prydz K . 2005 . A proteoglycan undergoes different modiﬁcations en route to the apical and basolateral surfaces of Madin – Darby canine kidney cells . J Biol Chem 280 : 29596 – 29603 . Utriainen A , Sormunen R , Kettunen M , Carvalhaes LS , Sajanti E , Eklund L , Kauppinen R , Kitten GT , Pihlaja - niemi T . 2004 . Structurally altered basement membranes and hydrocephalus in a type XVIII collagen deﬁcient mouse line . Hum Mol Genet 13 : 2089 – 2099 . van den Hoven MJ , Rops AL , Bakker MA , Aten J , Rutjes N , RoestenbergP , GoldschmedingR , ZchariaE , VlodavskyI , van der Vlag J , et al . 2006 . Increased expression of hepar - anase in overt diabetic nephropathy . Kidney Int 70 : 2100 – 2108 . Vanpouille C , Deligny A , Delehedde M , Denys A , Melchior A , Lienard X , Lyon M , Mazurier J , Fernig DG , Allain F . 2007 . The heparin / heparan sulfate sequence that interacts with cyclophilin B contains a 3 - O - sulfated N - unsubstituted glucosamine residue . J Biol Chem 282 : 24416 – 24429 . Varki A , Etzler ME , Cummings RD , Esko JD . 2009 . Discov - ery and classiﬁcation of glycan - binding proteins . In Essentials of glycobiology ( ed . A Varki , et al . ) , pp . 375 – 386 . Cold Spring Harbor Laboratory , Cold Spring Harbor , NY . Viviano BL , Silverstein L , Pﬂederer C , Paine - Saunders S , Mills K , Saunders S . 2005 . Altered hematopoiesis in glypican - 3 - deﬁcient mice results in decreased osteoclast differentiation and a delay in endochondral ossiﬁcation . Dev Biol 282 : 152 – 162 . Vogl - Willis CA , Edwards IJ . 2004 . High glucose - induced alterations in subendothelial matrix perlecan leads to increased monocyte binding . Arterioscler Thromb Vasc Biol 24 : 858 – 863 . VreysV , DavidG . 2007 . Mammalianheparanase : Whatisthe message ? J Cell Mol Med 11 : 427 – 452 . Waern I , Jia J , Pejler G , Zcharia E , Vlodavsky I , Li JP , Wer - nersson S . 2010 . Accumulation of Ym1 and formation ofintracellularcrystallinebodiesinalveolarmacrophageslackingheparanase . Mol Immunol 47 : 1467 – 1475 . Wang LC , Brown JR , Varki A , Esko JD . 2002 . Heparin’s anti - inﬂammatory effects require glucosamine 6 - O - sulfation Heparan Sulfate Proteoglycans Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 31 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from and are mediated by blockade of L - and P - selectins . J Clin Invest 110 : 127 – 136 . Wang L , Fuster M , Sriramarao P , Esko JD . 2005 . Endothelial heparan sulfate deﬁciency impairs L - selectin - and chemokine - mediated neutrophil trafﬁcking during inﬂammatory responses . Nat Immunol 6 : 902 – 910 . Watt FM , Fujiwara H . 2011 . Cell – extracellular matrix inter - actions in normal and diseased skin . Cold Spring Harb Perspect Biol 3 : a005124 . WernerssonS , BragaT , SawesiO , WaernI , NilssonKE , Pejler G , AbrinkM . 2009 . Age - relatedenlargementoflymphoid tissue and altered leukocyte composition in serglycin - deﬁcient mice . J Leuk Biol 85 : 401 – 408 . West L , Govindraj P , Koob TJ , Hassell JR . 2006 . Changes in perlecan during chondrocyte differentiation in the fetal bovine rib growth plate . J Orthop Res 24 : 1317 – 1326 . Westphal V , Murch S , Kim S , Srikrishna G , Winchester B , Day R , Freeze HH . 2000 . Reduced heparan sulfate accu - mulation in enterocytes contributes to protein - losing enteropathy in a congenital disorder of glycosylation . Am J Pathol 157 : 1917 – 1925 . WijnhovenTJ , LensenJF , RopsAL , vanderVlagJ , KolsetSO , BangstadHJ , PfefferP , vandenHovenMJ , BerdenJH , van den Heuvel LP , et al . 2006 . Aberrant heparan sulfate pro - ﬁle in the human diabetic kidney offers new clues for therapeuticglycomimetics . AmJKidneyDis 48 : 250 – 261 . Wijnhoven TJ , Lensen JF , Wismans RG , Lamrani M , Mon - nens LA , Wevers RA , Rops AL , van der Vlag J , Berden JH , van den Heuvel LP , et al . 2007a . In vivo degradation of heparan sulfates in the glomerular basement mem - brane does not result in proteinuria . J Am Soc Nephrol 18 : 823 – 832 . WijnhovenTJ , LensenJF , WismansRG , LefeberDJ , RopsAL , van der Vlag J , Berden JH , van den Heuvel LP , van Kup - pevelt TH . 2007b . Removal of heparan sulfate from the glomerular basement membrane blocks protein passage . J Am Soc Nephrol 18 : 3119 – 3127 . Wilcox - Adelman SA , Denhez F , Goetinck PF . 2002 . Syndecan - 4modulatesfocaladhesionkinasephosphory - lation . J Biol Chem 277 : 32970 – 32977 . Williams KJ , Fuki IV . 1997 . Cell - surface heparan sulfate proteoglycans : Dynamic molecules mediating ligand catabolism . Curr Opin Lipidol 8 : 253 – 262 . Wittrup A , Zhang SH , Svensson KJ , Kucharzewska P , Johansson MC , Morgelin M , Belting M . 2010 . Magnetic nanoparticle - based isolation of endocytic vesicles reveals a role of the heat shock protein GRP75 in macromolecu - lar delivery . Proc Natl Acad Sci 107 : 13342 – 13347 . Woods A , Longley RL , Tumova S , Couchman JR . 2000 . Syndecan - 4 binding to the high afﬁnity heparin - binding domainof ﬁbronectindrivesfocal adhesionformation in ﬁbroblasts . Arch Biochem Biophys 374 : 66 – 72 . Woulfe DS , Lilliendahl JK , August S , Rauova L , Kowalska MA , Abrink M , Pejler G , White JG , Schick BP . 2008 . Ser - glycin proteoglycan deletion induces defects in platelet aggregation and thrombus formation in mice . Blood 111 : 3458 – 3467 . XuD , FusterMM , LawrenceR , EskoJD . 2010a . Heparansul - fate regulates VEGF165 And VEGF121 - mediated vascu - lar hyperpermeability . J Biol Chem 286 : 734 – 745 . Xu Z , Ichikawa N , Kosaki K , Yamada Y , Sasaki T , Sakai LY , KurosawaH , HattoriN , Arikawa - HirasawaE . 2010b . Per - lecan deﬁciencycauses muscle hypertrophy , a decrease in myostatin expression , and changes in muscle ﬁber com - position . Matrix Biol 29 : 461 – 470 . XuC , RoslerE , JiangJ , LebkowskiJS , GoldJD , O’SullivanC , Delavan - Boorsma K , Mok M , Bronstein A , Carpenter MK . 2005a . Basic ﬁbroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium . Stem Cells 23 : 315 – 323 . Xu J , Park PW , Kheradmand F , Corry DB . 2005b . Endoge - nous attenuation of allergic lung inﬂammation by syndecan - 1 . J Immunol 174 : 5758 – 5765 . Xu RH , Peck RM , Li DS , Feng X , Ludwig T , Thomson JA . 2005c . Basic FGF and suppression of BMP signaling sus - tain undifferentiatedproliferationof humanES cells . Nat Methods 2 : 185 – 190 . Yamada S , Morimoto H , Fujisawa T , Sugahara K . 2007 . Glycosaminoglycans in Hydra magnipapillata ( Hydro - zoa , Cnidaria ) : Demonstration of chondroitin in the developing nematocyst , sting organelle , and structural characterization of glycosaminoglycans . Glycobiology 17 : 886 – 894 . YamaguchiY , InataniM , MatsumotoY , OgawaJ , IrieF . 2010 . Roles of heparan sulfate in mammalian brain develop - ment current views based on the ﬁndings from Ext1 con - ditional knockout studies . Prog Mol Biol Transl Sci 93 : 133 – 152 . Yan D , Lin X . 2009 . Shaping morphogen gradients by pro - teoglycans . Cold Spring Harb Perspect Biol 1 : a002493 . Yayon A , Klagsbrun M , Esko JD , Leder P , Ornitz DM . 1991 . Cell surface , heparin - like molecules are required for binding of basic ﬁbroblast growth factor to its high afﬁn - ity receptor . Cell 64 : 841 – 848 . YeS , Luo YD , Lu WQ , JonesRB , LinhardtRJ , Capila I , Toida T , Kan M , Pelletier H , McKeehan WL . 2001 . Structural basis for interaction of FGF - 1 , FGF - 2 , and FGF - 7 with different heparan sulfate motifs . Biochemistry 40 : 14429 – 14439 . Zak SM , Schuksz M , Koyama E , Mundy C . Wells DE , Yama - guchi Y , Paciﬁci M , Esko JD . 2011 . Compound heterozy - gous loss of Ext1 and Ext2 is sufﬁcient for formation of multiple exostoses in mouse ribs and long bones . Bone 48 : 979 – 987 . Zcharia E , Zilka R , Yaar A , Yacoby - Zeevi O , Zetser A , Metzger S , Sarid R , Naggi A , Casu B , Ilan N , et al . 2005 . Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models . FASEB J 19 : 211 – 221 . Zcharia E , Jia J , Zhang X , Baraz L , Lindahl U , Peretz T , Vlo - davsky I , Li JP . 2009 . Newly generated heparanase knock - out mice unravel co - regulation of heparanase and matrix metalloproteinases . PLoS ONE 4 : e5181 . Zernichow L , Abrink M , Hallgren J , Grujic M , Pejler G , Kol - setSO . 2006 . Serglycinisthemajorsecretedproteoglycan inmacrophagesandhasaroleintheregulationofmacro - phage tumor necrosis factor - a secretion in response to lipopolysaccharide . J Biol Chem 281 : 26792 – 26801 . Zhai L , Chaturvedi D , Cumberledge S . 2004 . Drosophila wnt - 1 undergoes a hydrophobic modiﬁcation and is tar - geted to lipid rafts , a process that requires porcupine . J Biol Chem 279 : 33220 – 33227 . S . Sarrazin et al . 32 Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from Zhang L , Lawrence R , Frazier BA , Esko JD . 2006 . CHO gly - cosylation mutants : Proteoglycans . Methods Enzymol 416 : 205 – 221 . ZimmermannP , ZhangZ , DegeestG , MortierE , LeenaertsI , Coomans C , Schulz J , N’Kuli F , Courtoy PJ , David G . 2005 . Syndecan recycling [ corrected ] is controlled by syntenin - PIP2 interaction and Arf6 . Dev Cell 9 : 377 – 388 . Zoeller JJ , Whitelock JM , Iozzo RV . 2009 . Perlecan regulates developmental angiogenesis by modulating the VEGF - VEGFR2 axis . Matrix Biol 28 : 284 – 291 . Zuberi RI , Ge XN , Jiang S , Bahaie NS , Kang BN , Hosseink - hani RM , Frenzel EM , Fuster MM , Esko JD , Rao SP , et al . 2009 . Deﬁciency of endothelial heparan sulfates at - tenuates allergic airway inﬂammation . J Immunol 183 : 3971 – 3979 . Heparan Sulfate Proteoglycans Cite this article as Cold Spring Harb Perspect Biol 2011 ; 3 : a004952 33 on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from 20 , 2011 2011 ; doi : 10 . 1101 / cshperspect . a004952 originally published online June Cold Spring Harb Perspect Biol Stephane Sarrazin , William C . Lamanna and Jeffrey D . Esko Heparan Sulfate Proteoglycans Subject Collection Extracellular Matrix Biology and Vertebrates Mechanisms Conserved between Invertebrates Extracellular Matrix in Development : Insights from Nicholas H . Brown in Development and Disease Extracellular Matrix Degradation and Remodeling Pengfei Lu , Ken Takai , Valerie M . Weaver , et al . ThrombosisExtracellular Matrix Proteins in Hemostasis and Wolfgang Bergmeier and Richard O . Hynes Extracellular Matrix Constituents and Functions An Inventory of - - Overview of the Matrisome Richard O . Hynes and Alexandra Naba The Thrombospondins Josephine C . Adams and Jack Lawler Integrins in Cell Migration Anna Huttenlocher and Alan Rick Horwitz Integrins , and the Extracellular Matrix Signaling Pathways , b Cross Talk among TGF - John S . Munger and Dean Sheppard FunctionsFibronectins , Their Fibrillogenesis , and In Vivo Jean E . Schwarzbauer and Douglas W . DeSimone Heparan Sulfate Proteoglycans Jeffrey D . Esko Stephane Sarrazin , William C . Lamanna and SystemExtracellular Matrix : Functions in the Nervous MüllerClaudia S . Barros , Santos J . Franco and Ulrich The Collagen Family Sylvie Ricard - Blum AdhesionsMolecular Architecture and Function of Matrix Benjamin Geiger and Kenneth M . Yamada ModulationTenascins and the Importance of Adhesion Ruth Chiquet - Ehrismann and Richard P . Tucker and Diseased Skin Cell - Extracellular Matrix Interactions in Normal Fiona M . Watt and Hironobu Fujiwara Integrin Structure , Activation , and Interactions Iain D . Campbell and Martin J . Humphries Genetic Analyses of Integrin Signaling Reinhard Fässler Sara A . Wickström , Korana Radovanac and http : / / cshperspectives . cshlp . org / cgi / collection / For additional articles in this collection , see Copyright © 2011 Cold Spring Harbor Laboratory Press ; all rights reserved on October 26 , 2017 - Published by Cold Spring Harbor Laboratory Press http : / / cshperspectives . cshlp . org / Downloaded from